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Abstract 
Bacterial Vaginosis (BV) is the most common of vaginal infections diagnosed amongst women 
of child bearing years. Yet, there is very little insight as to how it occurs. There are a vast 
number of criteria that can be taken into consideration in determining the presence of BV. The 
purpose of this thesis is two-fold: first, to discover the most significant features necessary to 
diagnose the infection, and second, to apply various classification algorithms on the selected 
features. In order to fulfill our purpose, we conducted an array of experiments on the data. We 
tested the full set of raw data, removed the time series features, tested the medical and clinical 
features in isolation, cleaned the data and performed the same experiments on the clean full, 
clean clinical and clean medical datasets. We compared the accuracy, precision, recall and F-
measure and time elapsed for each feature selection and classification grouping. It is observed 
that certain feature selection algorithms provided only a few features; however, the classification 
results were as good as using a large number of features. After comparing all of the experiments, 
the algorithms performed best on the raw full and clean full datasets. However, the raw full 
dataset returned better comprehensive results. 
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CHAPTER 1 
Introduction 
1.1 Introduction  
Machine learning (ML) algorithms are centered around predictions based on 
generalizations created from previous examples. The provision of larger amounts of data allows 
for tackling larger problems (Domingos, 2012). ML transforms massive amounts of raw data into 
knowledge that becomes useful for the analyst. It is employed in business, academia, 
government, science and other industries. Its utilization runs the gamut and has been applied to 
many different types of data including fraud detection (Akoglu & Faloutsos, 2013), business 
negotiations (Jim, 1996), facial recognition (Joseph Shelton et al., 2011), email messages 
(Kiritchenko & Matwin, 2011) and many other applications. New ML algorithms are being 
developed and computers are becoming more powerful, which can lend itself to addressing 
complex problems with more accuracy and expeditiousness in a way that is practically 
impossible for humans. 
The medical field is quickly embracing machine learning methodologies as these 
approaches have shown progress in their usefulness in prediction and classification. This 
implementation could prove useful in discovering ways to lower the cost of medication, improve 
clinical studies and help facilitate better assessments by physicians (Salama, Abdelhalim, & 
Zeid, 2012). ML can improve the healthcare process as data continues to increase and decrease 
the human effort that would traditionally be required. It has been used in the medical field to 
diagnose lung cancer (Kancherla & Mukkamala), breast cancer (Osareh & Shadgar, 2010), 
asthma (Prasad, Prasad, & Sagar, 2011), heart disease (Al-Shayea, 2011), dementia (Williams, 
Weakley, Cook, & Schmitter-Edgecombe, 2013) and other diseases and conditions. ML has 
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recently been used to compare the performance of a variety of classification algorithms in 
detecting breast cancer (Yau & Othman, 2007). The algorithms compared were Bayes Network, 
Radial Basis Function Networks (RBF), Pruned Tree, Single Conjunctive Rule Learner and 
Nearest Neighbors Algorithm.  
There is a minimal amount of published research using supervised machine learning to 
diagnose BV. In the past few years and as recent as this year, Srinivasan et al. (2012), Ravel et 
al. (2011) and Beck & Foster (2014) have used both supervised and unsupervised machine 
learning techniques to classify BV related microbiota. However, we are expanding this research 
by conducting experiments using a different dataset. 
  In this thesis, we use a myriad of feature selection and classification algorithms to 
identify Bacterial Vaginosis (BV) in women. BV is a very common condition that is signified by 
changes in vaginal microbiota or microflora. The rest of this thesis is organized as follows. 
Section 1.2 discusses the motivation and challenges for this research. Chapter 2 features related 
work in the areas of Bacterial Vaginosis and machine learning. Chapter 3 provides details about 
machine learning, the feature selection, search method and classification algorithms used for this 
research and the Weka workbench used to process the data. Chapter 4 describes the dataset, 
experiment process and the metrics used to analyze the performance of the algorithms. Chapter 5 
examines the experiments conducted and the results. Finally, Chapter 6 will present the 
conclusion and future work. 
1.2 Motivation and Problem Statement  
There are several diseases which arise because of changes in the microbial communities 
in the body. Scientists continue to conduct research in a quest to find the catalysts that provoke 
these changes in the naturally occurring microbiota. The human body can be very sensitive to 
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change and while the structure of the body is generally the same for everyone; each person has 
unique qualities and this can include the makeup of microbial communities. Are these microbial 
differences due to genetics, environment, behavior and/or a combination of the three?  
Bacterial Vaginosis (BV) is a disease that fits the above criteria. BV afflicts 
approximately 29% of women in child bearing age. Typically women are asked a series of 
questions and are then tested via vaginal swab to confirm diagnosis, but the root causes continue 
to elude scientists. The challenge becomes finding a common set of attributes that can begin 
providing answers to the aforementioned question. The additional challenges include 
determining the optimal methods for diagnosis resulting in accuracy, efficiency and time and 
cost savings. Do we solely rely on the experience and competence of physicians or should we 
look to computer aided medical diagnosis? Machine learning has been used in many domains 
including medical diagnosis, but is it an effective tool for the diagnosis of BV? If so, which 
feature selection and classification algorithms are the best to use on a particular dataset or is it a 
“one size fits all” solution?   
This research is targeted at finding a common set of attributes or features that are 
correlated with a BV positive diagnosis and will begin looking at which machine learning feature 
selection and classification algorithm combinations that will optimize diagnosis.  
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CHAPTER 2 
Related Work 
2.1 Bacterial Vaginosis  
As highlighted in chapter 1, BV is often characterized by changes in the vaginal 
microbiota; unfortunately, the causes of those changes are not well understood. Fortunately, it is 
easily treatable with antibiotics such as metronidazole and clindamycin (Srinivasan et al., 2012). 
BV is most often diagnosed by testing the vaginal fluid via Gram stain and/or by an assessment 
based on Amsel’s clinical criteria. The Gram stain produces a Nugent Score ranging from 1 – 10. 
A score of seven or greater yields a positive BV diagnosis. On the other hand, three of the 
following four Amsel’s criteria must be present for a positive diagnosis: 1) presence of a fishy 
like odor, 2) presence of a white discharge, 3) a vaginal pH of > 4.5 and 4) a minimum of 20% 
“clue cells” detection (Brotman, 2011). However, Nugent’s criterion has become the gold 
standard for diagnosis (Rangari Amit, Parmjit, & Sharma, 2013). In many instances, a diagnosis 
is made with Amsel’s clinical criteria and confirmed with Gram stain. One of the problems 
women face is that they may be asymptomatic, however, BV positive (Sujatha et al., 2013).  BV 
can cause unfavorable outcomes for women including an odorous discharge, pelvic inflammatory 
disease (PID), premature labor and cause them to be more susceptible to contracting HIV and 
other sexually transmitted diseases (STDs), (Fredricks, Fiedler, Thomas, Oakley, & Marrazzo, 
2007). The rate at which BV reoccurs is very high and also not well understood. 
Srinivasan et al. (2012) performed deep sequencing of the 16S rRNA gene in an attempt 
to uncover the variety and make-up of vaginal bacteria in BV positive women. They discovered 
that there were only two bacteria, Leptotrichia amnionii and Eggerthella sp. that were linked to 
all four of Amsel’s criteria. They also uncovered the fact that there was a greater presence of 
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Lactobacillus crispatus or Lactobacillus iners in women without BV. Unsupervised machine 
learning (clustering) was one of the methodologies used to make taxonomic connections with 
BV. They concluded that vaginal bacteria biota in women with BV is varied and in greater 
quantities in addition, there was no single bacterium present in 100% of the women. 
Beck & Foster (2014) applied genetic programming, random forests, and logistic 
regression machine learning techniques on two BV datasets from Srinivasan et al. (2012) and 
Ravel et al. (2011) to hopefully discover BV related microbial relationships. While the 
associated microbe clusters were different in the two datasets, they did discover that some of the 
clusters had overlapping microbes. They performed experiments on both the Nugent score and 
Amsel’s criteria. Their experiments resulted in logistic regression and random forest 
outperforming genetic programming. On the Nugent score, logistic regression and random forest 
maintained accuracy between 90% and 95%. Amsel’s criteria produced slightly lower accuracy. 
However, none of the three classification algorithms fell below 80% accuracy. 
2.2 Machine Learning in Medical Diagnosis 
In the world of medicine, machine learning (ML) has been used in the process of 
simplifying diagnoses and minimizing misdiagnoses. However, it must be noted that this 
technology is a tool and does not replace the role of the physician; instead, it should be used to 
aid in the overall diagnostic process and evaluation of patients. Computer scientists’ use of ML 
techniques on medical data is continuing to rise as they look for patterns to assist with diagnoses 
and enhancement of patient care (Savage, 2012). As we see improvements and the generation of 
new ML algorithms, we will see a decrease in the time it takes to diagnose and an increase in 
precision, effectiveness and satisfied patients. ML algorithms have gained a much deserved 
reputation in research for use in assisting with the diagnoses of numerous diseases (Filippo, 
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Alberto, Eladia Maria, Petr, & Josef, 2013). We will explore a few current applications of 
machine learning in the realm of medical diagnosis research. As we will come to see, there is not 
a “one size fits all” machine learning solution for the vast variety of medical challenges.  
We will begin our exploration with heart disease, as it is the primary cause of death 
worldwide. The World Health Organization (2014) published that almost 17 million lives were 
lost in 2011 worldwide due to cardiovascular diseases. This amounts to three in ten deaths. 
While these numbers seem alarming (and they are), they were the same in 2008. With all of the 
information, research and other resources available, why aren’t these numbers decreasing? In 
2010 alone, the financial consequence (direct and indirect) in the United States was an estimated 
cost of $315.4 billion (Go et al., 2013).  
The process for diagnosing heart disease can be quite extensive requiring patients to take 
numerous tests and are many times dependent upon the experience and proficiency of the 
physician. Unfortunately, some of these tests do not lead to an accurate diagnosis and treatment 
of the disease. With the use of ML, there is the possibility of increasing accuracy and reducing 
the features in the prediction of heart disease. Anbarasi, Anupriya, & Iyengar (2010) used a 
dataset with 909 instances and 13 features. By using Correlation-Based Feature Subset 
Evaluation (CfsSubsetEval) combined with Genetic Search. They were able to achieve a reduced 
feature set containing only six key features. They chose three classification algorithms: Naïve 
Bayes, Decision Tree and Classification via Clustering. Experiments using the three 
classification algorithms were performed on both the original dataset and the dataset with 
reduced features to validate the accuracy. Decision Tree (99.2%) ranked first after applying 
feature selection, the accuracy of Naïve Bayes (96.5%) remained steady on both the original and 
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reduced datasets and Classification via Clustering (88.3%) produced low results compared to the 
other two algorithms.   
Cancer is the second leading cause of death worldwide with lung cancer as the number 
one cause of cancer death. The American Cancer Society has predicted that in 2014 there will be 
224,201 new cases of lung cancer and predicted to claim 159,260 lives in the Unites States alone 
(American Cancer Society, 2014). Lung cancer like most cancers, can begin to progressively 
spread to other organs if it goes untreated, and even then, there’s a possibility that the treatment 
may not work. In order to increase the likelihood of eradicating the cancer and increasing the 
survival rate, early detection and treatment is quintessential. Unfortunately, some of the current 
testing methods such as Computed Tomography scan (CT scan), chest radiography and Sputum 
analysis either require an extensive amount of time, money and/or can only detect the cancer in 
its advanced stage, thus, lowering the chances of survival (Taher & Sammouda, 2011).  
Researchers continue to experiment with machine learning algorithms employing mostly 
supervised learning as an alternate means for classifying cancer. Hosseinzadeh, KayvanJoo, 
Ebrahimi, & Goliaei (2013) compared Support Vector Machines (SVM), Naïve Bayes and 
Artificial Neural Networks (ANN) in their ability to accurately identify and predict the specific 
type of lung tumor based on a number of factors such as the structure of the tumor. They 
determined that the SVM algorithm at 88% accuracy was the top performer of the three and that 
classification and feature selection had great potential in simple applications.  
Only second to lung cancer, breast cancer is very invasive and the most primary cause of 
cancer related death amid women (Salama et al., 2012). ML has often been applied in diagnosing 
and detecting breast cancer because it has the ability to identify patterns that may be otherwise 
difficult to detect, as well as learn from previous instances. While there has been much research, 
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it is still unknown what causes breast cancer. Due to this fact, early detection is imperative in 
reducing the death rate. Detection should be able to reliably and accurately differentiate between 
malignant and benign tumors. The customary technique for diagnosis is usually performed by 
human observation. However, the number of patients is increasing and therefore computers to 
aid and automate the diagnosis process have been developed in the past several years. The 
qualitative data is converted to a quantitative feature classification problem which has more 
objectivity (Osareh & Shadgar, 2010).  
 Yau & Othman (2007) compare the accuracy, time and error rate of five classification 
algorithms on breast cancer data that consisted of 699 rows and 9 columns of data. The 
algorithms compared were Bayes network classifier, radial basis function, decision tree and 
single conjunctive rule learner. They determined that Bayes network classifier was the best 
algorithm of those compared based on the accuracy or the percentage of correctly classified 
instances of 89.71%, model build time of 0.19 seconds and average error at 0.2140. In 
comparison, Aruna, Rajagopalan, & Nandakishore (2011) evaluated three sets of breast cancer 
data in the areas of accuracy, precision, specificity and sensitivity. The Wisconsin Diagnostic 
Breast Cancer Dataset contained 569 instances and 32 features, Wisconsin Breast Cancer Dataset 
consisted of 683 instances (444 benign, 239 malignant) and Breast Tissue Dataset was comprised 
of 106 instances and 9 features. Naïve Bayes, SVM Gaussian RBF kernel (SVM-RBF), RBF 
neural networks, decision trees, J48 and simple classification and regression trees (CART) were 
applied to evaluate the performance of each algorithm. They determined based on their 
experiments that SVM-RBF was the top ranked performer in all areas. Both sets of breast cancer 
machine learning experiments were conducted using the Weka workbench. 
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 Asthma is a common lung disease that affects approximately 235 million people 
worldwide. That number is inclusive of the 25 million affected with asthma in the U.S. of which, 
7 million are children. In similar fashion as some of the aforementioned illnesses, the exact cause 
of asthma is unknown and may be a combination of environment and genetics. People are 
afflicted with asthma in varying degrees ranging from mild to acute and can sometimes become 
fatal if not treated timely. Typical symptoms of asthma are chest tightening, shortness of breath, 
wheezing and coughing. Asthma diagnoses is usually attained by a physician performing a series 
of tests that may include: Spirometry (tests the lung function), chest x-ray, EKG and 
bronchoprovocation among others (National Heart, Lung and Blood Institute, 2014).  
Physicians will often use a stethoscope as a non-invasive way to listen for sounds 
produced by the lungs; this method can be unreliable for many reasons including the physician’s 
hearing ability and the frequency of the sounds. There is a recent study using computerized lung 
sound analysis that has the potential to help physicians make quicker and more accurate 
diagnoses. Emanet, Öz, Bayram, & Delen (2014) use an embedded real-time microprocessor 
system and an inexpensive microphone to transmit the sounds. After the data was retrieved, they 
applied Random Forest, AdaBoost combined with Random Forest and artificial neural networks 
(ANN) machine learning algorithms for classification. Random Forest and AdaBoost combined 
with Random Forest performed well reaching an accuracy of approximately 90%, while ANNs 
were at about 80%. 
The final disease we will explore using ML techniques as a diagnostic tool is Alzheimer’s 
disease (AD). The most common cause of dementia is Alzheimer’s disease. It manifests as 
memory loss and the deterioration of other intellectual capabilities that impedes the normal way 
of living. While there has been and still is lots of research to find a cure for Alzheimer’s, one has 
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not been discovered as of yet. The best available remedies merely have the ability to retard the 
dementia symptoms in order to increase the length of experiencing a good quality of life 
(Alzheimer's Association, 2014).  
Changes in the structure and function of the brain have been assessed using diagnostic 
tools such as a magnetic resonance imaging (MRI), computer-aided diagnosis (CAD) and single-
photon emission computed tomography (SPECT). However, Yasuo et al. (2013) found that there 
was not any current research using classification based on MRI images alone. They applied a 
support vector machine (SVM) and an artificial neural network (ANN) to a dataset containing 
four morphological and six functional images on 30 patients (15 with AD and 15 without AD). 
Unfortunately, their results were much lower than classification based on data retrieved from 
baseline principal component analysis (PCA) and SPECT images. The experiments yielded 
0.660 on morphological and 0.903 on functional images using SVM for classification. They 
attributed the low rates to the meager dataset and lack of algorithm variety. 
2.3 Machine Learning in Other Real World Applications 
Machine learning (ML) not only finds its place in the field of medicine, but has also been 
very beneficial in other applications such as education, science, security, business and so on. 
Algorithm performance is often highlighted as a ML outcome, and should be, but there are others 
that should also be taken into consideration such as increase in quality of life, lives saved, 
interventions implemented and time, effort and money conserved to name a few. These 
additional outcomes can help connect ML to other real world problems.  It’s not enough to 
simply run an algorithm on dataset, it should include determining the most relevant features, 
analyzing and interpreting the results and convincing others that this technique is worthwhile for 
large scale implementation (Wagstaff, 2012). 
13 
 
 
The field of biometrics has embraced machine learning to assist in the identification and 
authentication process. There are several modes of biometric identification including 
fingerprints, iris, signature, voice and face.  Shelton et al. (2012) developed the Genetic and 
Evolutionary Feature Extraction – Machine Learning (GEFEML) algorithm for facial recognition 
in the area of Genetic & Evolutionary Biometrics (GEB). This algorithm works based on the 
principles of Darwinism’s natural selection. They compared the performance of their GEFEML 
with that of the traditional Local Binary Pattern (LBP) feature extraction technique. GEFEML 
accuracy was comparable to LBP and reduced processing time by 45% (in terms of 
computational complexity).  
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CHAPTER 3 
Exploring and Identifying Appropriate Feature Selection and Classification Algorithms 
3.1 Machine Learning  
Machine learning (ML) was birthed in the 1930s beginning with Ronald A. Fisher and in 
the 1950s with linear perceptron from Frank Osenblatt. From the 1960s until the late 1980s, ML 
experienced highs and lows, however, things began looking up with the entrance of neural 
networks. The 1990s brought about the resurrection of ML with support vector machines (SVM) 
(Alexander, 2013). Over the past decade, it has been a rapidly developing field and has often 
been applied successfully to complex and real world challenges.  
Machine learning utilizes a variety of artificial intelligence and statistical tools to train on 
past data in order to create reasonable generalizations, discover patterns, classify previously 
unseen data or predict new directions (Hosseinzadeh et al., 2013). The primary objective of ML 
is to minimize classification errors on the training data. It has the ability to deliver precise or 
nearly perfect predictions (Anu, Agrawal, & Bhattacharya, in-press). ML works extremely well 
on massive datasets that may go beyond the bounds of human analyzation and interpretation.  
The term machine learning is often mistakenly used interchangeably with data mining. 
While data mining can make use of ML algorithms, such as SimpleKMeans in a clustering 
application, the emphasis is different. Data mining attempts to search through data to gather 
information that can be converted into a structure that is comprehensible for further use. In other 
words, it is a knowledge discovery process. As previously mentioned, ML emphasizes 
generalization, prediction and representation. There are many machine learning packages on the 
market that each has a host of algorithms for exploration. Figure 1 displays a few of the open 
source packages. 
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Figure 1. Open source machine learning software packages. 
Machine learning algorithms are generally classified into two learning schemes: 
supervised and unsupervised learning. The type and availability of data and the anticipated 
outcome will determine which learning scheme will be employed (Dua, 2011). In supervised 
learning, the output values of the model are defined prior to creating it, such as BV positive or 
negative. In contrast, the model itself dictates its output for unsupervised learning (Kantardzic, 
2003). The most familiar tasks of supervised learning are regression and classification. This 
research focuses on the task of classification learning, which will be defined later. 
3.2 Feature Selection and Classification 
 3.2.1 Feature selection. Feature selection (FS) is the process of choosing the most 
significant features and forming a subgroup or subset that will be the most valuable for 
prediction and analysis. The goal is to discover a subset of features that perform as well (or 
better) than the original set. It is assumed that any given dataset contains data or features that are 
not relevant, duplicates and/or noisy data, thus necessitating feature selection (Hall, 1999). There 
are major benefits of applying this machine learning technique. FS reduces the amount of data 
that has to be analyzed in turn reducing storage and runtime. This pre-processing step may cost 
you time in the beginning, but will improve the outcome and efficiency in the end. This is 
especially true when dealing with enormous amounts of data. In addition, by executing FS we 
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can anticipate that algorithms will learn more quickly and accuracy will be improved because 
irrelevant features have been reduced or completely eliminated.  Simply stated, feature selection 
should produce top performance with minimal processing energy. 
Feature selection generally falls into one of two categories: minimum subset and feature 
ranking. Minimum subset algorithms produce exactly what the name suggests; it creates a subset 
of features with the least amount of relevant features that will yield maximum results. However, 
there is no distinction between the features in terms of ranking. On the other hand, feature 
ranking algorithms do not reduce the dataset, but instead it orders the features based on 
evaluation measures that have been specified (Kantardzic, 2003).  
The two primary FS approaches fall within the two categories listed above: filter methods 
and wrapper methods.  Filters create a subset before learning begins that is the most favorable. 
Based on overall characteristics, an autonomous evaluation is made. Because filters run much 
faster than wrappers, they may be the preferred method for large and highly dimensional datasets 
(Witten, Frank, & Hall, 2011).  Wrappers assess the subset by “wrapping around” a classification 
algorithm that will be used for learning. They usually outperform filters in terms of accuracy; 
however, the computational cost is very high when used on large datasets. Feature selection 
algorithms are typically coupled with a search method such as genetic search, exhaustive search 
and best first (Rajarajeswari & Somasundaram, 2012).   A given search method will roam 
through the features in order to locate good subsets.  
3.2.2 Classification. Classification, as previously mentioned, is one of two supervised 
learning techniques. The objective of a classifier algorithm is to accurately group objects into a 
predefined set of classes. In other words, it predicts the class of each instance (Dua, 2011). This 
approach is mostly used in artificial intelligence (AI), machine learning and pattern recognition. 
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Just as with machine learning, classification has been used in a variety of applications such as 
medical diagnosis, biometrics, cybersecurity, risk analysis, manufacturing, etc. (Anbarasi et al., 
2010). There are a range of major classification techniques that include: Neural networks, 
Bayesian classifiers, meta learners, decision trees, etc. (David, Saeb, & Al Rubeaan, 2013). 
Choosing the best classifier for a particular problem is extremely important, yet this task has not 
been given much research attention (Peng, Kou, Ergu, Wu, & Shi, 2012).  
3.3 Weka 
Weka (Waikato Environment for Knowledge Analysis) was created at the University of 
Waikato in New Zealand and has a compilation of data preprocessing tools and machine learning 
algorithms. Weka’s interface allows users to easily use the tools and apply algorithms on a 
variety of datasets by accessing the “Explorer” through its graphical user interface (GUI) 
pictured in Figure 2. It was written in Java and runs on most operating systems such as 
Windows, Mac OS and Linux.  
  
Figure 2. Weka GUI. 
Figure 3 displays the following features in the Weka Explorer for working with data: 
Preprocessing, classification, clustering, association rule mining, attribute selection and 
visualization. Weka imports data files that are in the Attribute-Relation File Format (ARFF), 
comma-separated values file format (CSV) as well as a few others. Once you load your dataset, 
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there are many options to choose. These include classification and clustering options such as, 
cross-validation, percentage split and classes-to-cluster evaluation.   
 
Figure 3. Weka Explorer. 
The following section will list and describe all of the feature (attribute) selection, search 
method and classification algorithms we used for this research. 
3.4 Algorithms Used in Weka 
3.4.1 Feature selection algorithms. 
 CfsSubsetEval: Produces subsets of features that have a low association with each other 
and greatly interrelated with the class (Witten et al., 2011). 
 ClassifierSubsetEval: A wrapper method that uses a classifier to approximate the value of a 
set of attributes. The attribute subsets evaluated are derived from training or an isolated 
testing set of data (Witten et al., 2011). 
 ConsistencySubsetEval: Feature sets are assessed based on the level of class consistency. It 
searches for high class consistency with minimal features; however the subset consistency 
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cannot fall below the consistency of the full feature set (Chue-Poh, Ka-Sing, & Weng-Kin, 
2008).   
 FilteredSubsetEval: A filter is applied to the training data prior to performing feature 
selection. An error message will be generated if the filter alters the original features 
number or ordering (Witten et al., 2011). 
 WrapperSubsetEval: Similar to ClassifierSubsetEval, a classifier is used to determine the 
value of a subset of features. However, cross-validation is used to approximate the 
precision of the learning scheme for the feature subset (Witten et al., 2011). 
3.4.2 Search method algorithms. 
 BestFirst: Explores a random subset of features using greedy hill climbing and 
supplemented with backtracking. Backtracking is controlled by selecting the number of 
sequential non-improving nodes allowed. An empty set of features may be initially selected 
for a forward search, a full feature set for a backward search or begin midway and search 
both ways so that all possible distinct feature additions and deletions at any location can be 
examined (Sindhu, Geetha, & Kannan, 2012). 
 RankSearch: An attribute evaluator is used to rank all of the features. A forward selection 
search produces a ranked list using the selected subset evaluator. After the list is produced, 
each subset increments in size and is then evaluated. It begins with the best feature then the 
best feature plus the next best feature until it produces the best subset which is reported 
(Witten et al., 2011). 
 GeneticSearch: Based on the principles of evolution’s survival of the fittest, the genetic 
search begins with an empty feature set along with rules generated randomly for the initial 
population. Afterwards, new populations and offspring are formed from the rules of the 
20 
 
 
current population. Crossover and mutation are administered to create offspring. This 
process repeats until every rule in final population fulfills the fitness threshold (Anbarasi et 
al., 2010). 
 LinearForwardSelection: Is an extension of BestFirst. The user selects m number of 
features that should not be exceeded in each step. Runtime is reduced because the number 
of evaluations has been decreased. LinearForwardSelection uses one of two methods; fixed 
set or fixed width. Both rank the features using a subset evaluator. Fixed set uses only the 
m best features in the succeeding forward selection while fixed width increases k in each 
successive step (Gutlein, Frank, Hall, & Karwath, 2009).  
 SubsetSizeForwardSelection: Is an extension of LinearForwardSelection. The search 
executes k-folds cross validation that can be specified by the user. The prime subset-size is 
then chosen by executing a LinearForwardSelection on every fold. Lastly, the whole data 
set is used to execute a LinearForwardSelection up to the prime subset-size (Gutlein et al., 
2009). 
 GreedyStepwise: Executes a greedy backward or forward search through the area of feature 
subsets. It might start from a random place in the area or may start with all or none of the 
features. The search ends when adding or deleting any of the residual features causes a 
decrease in the evaluation. GreedyStepwise also has the ability to yield a ranked list of 
features by crisscrossing through the area and recording the order of the selected features 
(Witten et al., 2011). 
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3.4.3 Classification algorithms.  
 Bagging: Uses a random classifier and combines or aggregates copies of that classifier to 
improve performance. Bagging for classification takes a majority vote for a predicted class 
by a sequence of classifiers (Breiman, 1996). 
 RandomForest: A collection or ensemble of decision trees. It uses the outcomes of the trees 
that are individually “weak” classifiers to make one strong classifier. This is done by way 
of each tree voting on the most common class (Breiman, 2001). 
 LogitBoost: A boosting algorithm that uses logistic regression. Boosting increases the 
performance of classification by joining weak classifiers. It handles noisy data very well 
(Cai, Feng, Lu, & Chou, 2006). 
 KStar (K*): A nearest neighbor instance based learner. Instance based means that it 
compares pre-classified examples to classify an instance. Nearest neighbor finds the 
instance that is most similar in the training set  (Cleary & Trigg, 1995). 
 FT: Has the capacity to process both nominal and numeric features, binary and multi-class 
variables and missing values. The leaves have linear functions and angled splits. . (Witten 
et al., 2011). 
 J48: Written in Java and is derived from the C4.5 Revision 8 algorithm for use in the Weka 
workbench. This classifier is decision tree based. This means that it is configured like a 
tree. Tests are performed on one or more features creating non-leaf nodes (i.e. root node) 
and classification results are represented by leaf nodes. Classification takes place by 
beginning at the root of the tree, testing the node specific feature and generating a branch 
for each value. The method is repeated on each of the nodes on the branch and terminates 
when a leaf node is produced (Wang, Makedon, Ford, & Pearlman, 2005). 
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 AdaBoostM1: Uses a series of iterations during training to add weak learners thereby 
creating a strong learner. Each iteration adds a new weak learner to the collection and its 
weighting vector adjusts to concentrate on misclassified examples in previous cycles 
(Friedman, Hastie, & Tibshirani, 2000). 
 NaïveBayes: A simple probabilistic classifier based on the supposition of class conditional 
independence of features and that the prediction is not biased by any concealed features 
(John & Langley, 1995). 
 RBFNetwork: Comprised of three layers: input, hidden and output. It is similar to the k-
means algorithm in that the expected target value will most likely have similar values of 
those that are nearby. The name radial basis function derived its name because it uses 
radius distance (Sherrod, 2014). 
 OneR: one feature is tested by a set of rules and creates a one level decision tree (Witten et 
al., 2011). 
  
23 
 
 
CHAPTER 4 
Our Approach to Predict the Presence of Disease with Microbiome Community Etiology 
4.1 Dataset 
In this chapter, we provide our experiment process using the machine learning techniques 
defined in chapter three. We also define the evaluation metrics used to calculate the accuracy, 
precision, recall and F-measure in predicting the presence of the disease. The dataset used in our 
experiment is comprised of 25 women studied over a 10 week period. This data is a subset of a 
larger dataset of 400 women (Ravel et al., 2011). Dr. James A. Foster and Daniel Beck form the 
University of Idaho provided us with the de-identified data in a .csv file. The study was arranged 
so that samples and information were retrieved from the women every day during the 10 week 
period, however, some women missed days. There were also a few weeks that void of any data in 
the spreadsheet. There are a total of 1601 instances and 418 features. The BV data consists of 
three sub-categories of features: time series, clinical and medical data.  
4.1.1 Time series data. The time series data documents day and week numbers for 
features “DIA_DAY” and “DIA_WEEK” respectively (day 1, week 9), day of the week for 
feature “DAYOFWK” (Monday = 2), day number of the study for feature “TIME” (1, 2…70) 
and patient id number for feature P_ID (1, 2…25). The same data is repeated with the exception 
of “TIME” beginning with “P_ID.1” and so on. For our experiments, we used the data without 
the feature names. The numeric labels for this data range from features 1 – 11. A sample of the 
time series data with feature names are shown below in Table 1.  
Table 1 
Time Series Sample 
TIME P_ID SITE2 DIA_DAY DIA_WEEK DAYOFWK 
1 1 2 1 1 3 
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Table 1 
Cont. 
2 1 2 2 1 4 
3 1 2 3 1 5 
4 1 2 4 1 6 
5 1 2 5 1 7 
6 1 2 6 1 1 
7 1 2 7 1 2 
8 1 2 1 2 2 
9 1 2 2 2 4 
10 1 2 3 2 5 
 
4.1.2 Clinical data. The clinical data is a combination of results from Amsel’s criteria 
and a questionnaire. The questionnaire included questions such as sexual activity, contraceptive 
use, tobacco use, etc. The numeric labels for this data range from features 12 – 38. The clinical 
data feature names are displayed in Table 2.  
Table 2 
Clinical Data Features 
Clinical Data Features 
Vag_Int Sper_Use Fem_Powd Meds Vag_Itch 
Anal_Sex Lubr_Use Menstrua Swabs Vag_Burn 
Oral_Sex Partner Tampon Slide Vag_Dis 
Fing_Pen Thong Pad Ph_Glove 
 
Sexy_Toy Douching Stress Vag_Odor 
 
Cond_Use Fem_Spra Tob_Use Vag_Irr   
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4.1.3 Medical data. The medical data was obtained from vaginal swabs which were used 
to perform 454 sequencing of the V12 region of the 16S gene. The numeric labels for this data 
range from features 39 – 418. Table 3 exhibits the medical data feature names. 
Table 3 
Medical Data Features 
Medical Data Features 
Acholeplasma Bosea Helcobacillus Propioniferax 
Achromobacter Brachybacterium Helcococcus Propionimicrobium 
Acidaminococcus Bradyrhizobiaceae.1 Herbaspirillum Propionivibrio 
Acidimicrobiaceae.1 Bradyrhizobium Hydrogenophaga Proteobacteria.10 
Acidimicrobiaceae.2 Brevibacillus Hydrogenophilus Proteobacteria.11 
Acidimicrobiales.1 Brevibacterium Hyphomicrobiaceae.1 Proteobacteria.12 
Acidovorax Brevundimonas Ignatzschineria Proteobacteria.14 
Acinetobacter Burkholderia Incertae_Sedis_XII.1 Proteobacteria.15 
Actinobacteria.1 Burkholderiales.1 Incertae_Sedis_XII.2 Proteobacteria.16 
Actinobacteria.2 Caenimonas Janibacter Proteobacteria.17 
Actinobaculum Caldicellulosiruptor Janthinobacterium Proteobacteria.5 
Actinomycetales.1 Campylobacter Jeotgalicoccus Proteobacteria.6 
Actinomycetales.10 Capnocytophaga Jonquetella Proteobacteria.7 
Actinomycetales.11 Carboxydocella Kingella Proteobacteria.8 
Actinomycetales.12 Carboxydothermus Klebsiella Proteobacteria.9 
Actinomycetales.13 Carnobacteriaceae.1 Kocuria Pseudomonas 
Actinomycetales.14 Carnobacteriaceae.2 L.iners Pseudonocardiaceae.1 
Actinomycetales.15 Catenibacterium L.mucosae Pseudoxanthomonas 
Actinomycetales.16 Chromatiales.1 L.otu1 Psychrobacter 
Actinomycetales.17 Chryseobacterium L.otu6 Ralstonia 
Actinomycetales.2 Cloacibacterium L.reuteri Raoultella 
Actinomycetales.3 Clostridiales.1 Lachnospiraceae.10 Rheinheimera 
Actinomycetales.4 Clostridiales.10 Lachnospiraceae.2 Rhizobiales.1 
Actinomycetales.5 Clostridiales.11 Lachnospiraceae.3 Rhizobiales.2 
Actinomycetales.6 Clostridiales.12 Lachnospiraceae.4 Rhizobium 
Actinomycetales.7 Clostridiales.13 Lachnospiraceae.5 Rhodanobacter 
Actinomycetales.8 Clostridiales.14 Lachnospiraceae.6 Rhodococcus 
Actinomycetales.9 Clostridiales.15 Lachnospiraceae.7 Roseburia 
Aeromonadaceae.1 Clostridiales.16 Lachnospiraceae.8 Roseomonas 
Aeromonas Clostridiales.17 Lactobacillales.1 Rothia 
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Table 3 
Cont. 
Akkermansia Clostridiales.18 Lactobacillales.2 Rubrobacter 
Alistipes Clostridiales.19 Lactobacillales.3 Ruminococcaceae.1 
Alloscardovia Clostridiales.2 Lactobacillales.4 Ruminococcaceae.2 
Alphaproteobacteria.1 Clostridiales.20 Lactobacillales.5 Ruminococcaceae.3 
Alphaproteobacteria.2 Clostridiales.21 Lactococcus Ruminococcaceae.5 
Amaricoccus Clostridiales.3 Leptotrichia Ruminococcaceae.7 
Anoxybacillus Clostridiales.4 Leptotrichiaceae.1 Ruminococcaceae.8 
Aquabacterium Clostridiales.6 Leptotrichiaceae.2 Ruminococcus 
Aquincola Clostridiales.7 Leuconostoc Rummeliibacillus 
Archaea.1 Clostridiales.8 Marinobacter Saprospiraceae.1 
Archaea.2 Clostridiales.9 Marinomonas Sarcina 
Archaea.3 Clostridium Marmoricola Schlegelella 
Archaea.4 Collinsella Massilia Sedimentibacter 
Archaea.5 Comamonadaceae.1 Megamonas Selenomonas 
Archaea.6 Comamonas Meiothermus Shewanella 
Archaea.7 Coprobacillus Mesorhizobium Silanimonas 
Archaea.8 Coprococcus Methylobacillus Skermanella 
Archaea.9 Cupriavidus Methylobacterium Slackia 
Arthrobacter Cytophagaceae.1 Methyloversatilis Solibacillus 
Asaccharobacter Dechloromonas Microbacterium Solobacterium 
Aspromonas Deinococcus Mitsuokella Sphingobium 
Asticcacaulis Delftia Modestobacter Sphingomonas 
Atopobacter Dermabacter Mogibacterium Sphingopyxis 
Aurantimonas Dermacoccus Moryella Sporacetigenium 
Azonexus Desulfobacterium Mucilaginibacter Sporomusa 
Azospira Devosia Mycobacterium Stenotrophomonas 
Bacillaceae.1 Diaphorobacter Mycoplasma Streptomyces 
Bacillaceae.2 Dietzia Neisseria Streptophyta 
Bacillales.1 Dolosigranulum Neisseriaceae.1 Subdoligranulum 
Bacillariophyta Dorea Nesterenkonia Succinispira 
Bacilli.1 Dyella Nitratireductor Sutterella 
Bacilli.2 Dysgonomonas Nitrobacter Symbiobacterium 
Bacilli.3 Enhydrobacter Nocardioides Syntrophomonas 
Bacillus Enterobacter Nosocomiicoccus TM7_genera _incertae_sedis 
Bacteria.1 Enterobacteriaceae.1 Novosphingobium Tepidimonas 
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Table 3 
Cont. 
Bacteria.10 Enterobacteriaceae.2 Ochrobactrum Thermanaeromonas 
Bacteria.11 Enterococcaceae.1 Odoribacter Thermicanus 
Bacteria.12 Eremococcus Oligella Thermobacillus 
Bacteria.13 Erysipelothrix Oribacterium Thermolithobacter 
Bacteria.14 Erythrobacter Oscillibacter Thermomicrobia.1 
Bacteria.15 Escherichia.Shigella Paenibacillus Thermomonas 
Bacteria.16 Eubacterium Paludibacter Thermus 
Bacteria.17 Exiguobacterium Pantoea Treponema 
Bacteria.18 Facklamia Parabacteroides Trichococcus 
Bacteria.19 Fangia Paracoccus Turicibacter 
Bacteria.3 Fastidiosipila Parasutterella Ureaplasma 
Bacteria.4 Firmicutes.1 Pasteurella Varibaculum 
Bacteria.5 Firmicutes.2 Patulibacter Variovorax 
Bacteria.6 Flavisolibacter Pediococcus Veillonella 
Bacteria.7 Flavobacteriaceae.1 Pedobacter Veillonellaceae.1 
Bacteria.8 Flavobacteriaceae.2 Pelagibacter Veillonellaceae.2 
Bacteroidales.1 Flavobacteriaceae.3 Pelomonas Vibrio 
Bacteroidales.2 Flavobacterium Peptococcus Vogesella 
Bacteroidales.3 Fusobacterium Petrimonas Weeksella 
Bacteroides Gallicola Petrobacter Weissella 
Bacteroidetes.1 Gammaproteobacteria.1 Phascolarctobacterium Zimmermannella 
Bacteroidetes.2 Geobacillus Phenylobacterium Zoogloea 
Bacteroidetes.4 Geothrix Planifilum corGroup1 
Bacteroidetes.5 Globicatella Planococcus corGroup2 
Barnesiella Gp10 Planomicrobium corGroup3 
Bavariicoccus Gp6 Plesiomonas corGroup4 
Bifidobacterium Granulicatella Prevotellaceae.2 corGroup5 
Blastococcus Gulosibacter Propionibacteriaceae.1 corGroup6 
Blastomonas Haematobacter Propionibacteriaceae.2 corGroup7 
Blautia Haemophilus Propionibacterium corGroup8 
 
4.2 Experiment Process 
For all of our experiments, we used the Weka workbench explorer feature. The 
experiment process shown in Figure 4 will be outlined in this section in detail. We began by 
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converting the data into a format that was acceptable for use in Weka. The first column was an 
anonymous identifier for each woman; therefore, it was deleted because it was not part of the 
feature set. The Nugent score results were contained in the second column. If the Nugent score 
was ≥ 7 and ≤ 10, it was given a score of “1” indicating BV positive otherwise it was given a 
score of “0” indicating BV negative. We converted all numeric values to nominal values: 1’s to 
“yes” and 0’s to “no” in the nugentScoreBV column to grant access to a greater number of 
Weka’s algorithms. The data in the nugentScoreBV column was moved to the last column of the 
dataset as required by Weka for supervised learning. 
 
Figure 4. Experiment process. 
We used several of Weka’s attribute selection algorithms for our feature selection process 
and classifier algorithms to test the accuracy of diagnosing the presence of Bacterial Vaginosis 
(BV). Weka has two groups of feature selection algorithms: Attribute subset evaluators and 
single-attribute evaluators. The single-attribute evaluator algorithms reduce the feature set in 
theory in that it uses the ranker method and ranks all of the features in descending order. It 
requires the user to manually set a threshold to discard the lower ranking features or specify the 
number of features to preserve. We used five of the six attribute subset evaluator algorithms 
(each defined in Chapter 3) on the full training set because they automated the feature 
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selection/reduction process (CfsSubsetEval, ClassifierSubsetEval, ConsistencySubsetEval, 
FilteredSubsetEval and WrapperSubsetEval). Note that the CostSensitiveSubsetEval algorithm 
could not to be used because it did not produce any output for this dataset.  
Weka has two types of feature selectors: Search method and ranking method (11 total 
methods). We discarded the sole ranking method because it is only used with the single-attribute 
evaluator algorithms mentioned above. We then eliminated four of the remaining ten algorithms 
for one of two reasons: Processing time exceeded eight hours or the method failed to produce 
any output. The discarded search methods were ExhaustiveSearch, RaceSearch, RandomSearch, 
and ScatterSearchV1. During our feature selection process, we decided to use only two very 
popular algorithms (NaïveBayes and Bagging) for our WrapperSubsetEval algorithm. The 
default for ClassifierSubsetEval was the ZeroR algorithm, however, it only yielded one feature. 
Therefore, we decided to choose a very similar algorithm (OneR) to use for this feature selector. 
Weka has a total of 93 classification algorithms, 27 of which were not available for the 
type of dataset used, leaving 66 for classification. We quickly realized that it would be a 
formidable task to run experiments using all of the available algorithms. So to begin the 
classification process, we initially selected six popular algorithms (Bagging, ConjunctiveRule, 
J48, NaiveBayes, OneR and RandomForest). After administering the experiments, we discovered 
that OneR and ConjuctiveRule had the same output for all of the feature sets. In addition, they 
had lower accuracy than most of the other algorithms. Therefore, we chose to eliminate the 
OneR and ConjuctiveRule algorithms and replace them with RBFNetwork and AdaBoostM1 
then added an additional three algorithms (LogitBoost, KStar and FT) to increase the variety for 
our experiments. In Weka, deterministic algorithms such as RandomForest will yield repeatable 
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experiments because Weka uses a “seed value” to remove the randomization. In order to 
randomize the results, a manual manipulation of the seed value will be necessary. 
 Table 4 features the combinations of the five feature selection, six search methods and 
three classifier algorithms (used for wrapper methods) assembled to create 20 distinct feature 
selection sets.  
Table 4 
Feature Selection Sets 
Code Attribute Evaluator Search Method Classifier Algorithms 
FS1 CfsSubsetEval BestFirst  
FS2 CfsSubsetEval GeneticSearch  
FS3 CfsSubsetEval RankSearch  
FS4 ClassifierSubsetEval GeneticSearch OneR 
FS5 ConsistencySubsetEval BestFirst  
FS6 ConsistencySubsetEval GeneticSearch  
FS7 ConsistencySubsetEval LinearForwardSelection  
FS8 ConsistencySubsetEval RankSearch  
FS9 ConsistencySubsetEval SubsetSizeForwardSelection  
FS10 FilteredSubsetEval BestFirst  
FS11 FilteredSubsetEval GeneticSearch  
FS12 FilteredSubsetEval RankSearch  
FS13 WrapperSubsetEval BestFirst NaiveBayes 
FS14 WrapperSubsetEval BestFirst Bagging 
FS15 WrapperSubsetEval GeneticSearch Bagging 
FS16 WrapperSubsetEval GreedyStepwise NaiveBayes 
FS17 WrapperSubsetEval LinearForwardSelection NaiveBayes 
FS18 WrapperSubsetEval RankSearch NaiveBayes 
FS19 WrapperSubsetEval SubsetSizeForwardSelection NaiveBayes 
FS20 WrapperSubsetEval SubsetSizeForwardSelection Bagging 
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The nine classification algorithms used for our experiments are shown in Table 5. The 
default settings were maintained for all feature selection, search method and classification 
algorithms except as noted above where search methods were required for the feature selection 
process and classifiers for the wrapper methods. We saved the feature selection reports produced 
by Weka in Notepad++.  The actual reduced feature sets were saved as *.arff files that would 
then be imported back into Weka for the classification process. 
Table 5 
Classification Algorithms 
Code Algorithm 
A1 Bagging 
A2 RBFNetwork 
A3 J48 
A4 NaiveBayes 
A5 AdaBoostM1 
A6 RandomForest 
A7 LogitBoost 
A8 KStar (K*) 
A9 FT (Functional Trees) 
 
We used 10-fold cross-validation for testing and training. Holdout methods are 
commonly used when there is a limited quantity of data. In 10-fold cross-validation, the data is 
divided into 10 approximately equal parts or folds. The first fold is used for testing and folds two 
through ten are used for training. Each successive fold is used for testing and the remainders for 
training until all ten iterations are complete. The error rate is calculated for each of the 10 folds 
and averaged to produce comprehensive error estimation. According to Witten et al. (2011), 
theoretical substantiation and large-scale testing have shown that 10-folds seem to produce prime 
error estimations. 
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4.2.1 Raw Full Data Experiment Process. We conducted our first set of experiments on 
the full set of raw data that included all three data subsets: Time series, clinical and medical data. 
This data was untouched with the exception of making the adjustments required by Weka 
mentioned in section 4.1. This dataset included the cells and sometimes rows of missing data. 
We calculated the time taken for each feature selection and classification algorithm to produce 
output. We then created an elapsed time table. We additionally created a feature set and metrics 
table that will be presented in chapter 5. 
 4.2.2 Time Series Removed Experiment Process. We removed the columns containing 
the first eleven time series features detailed in section 4.1, leaving only the clinical and medical 
features for experiments. We applied feature selection and classification to this already reduced 
dataset. We calculated the time taken for each feature selection and classification algorithm to 
produce output. We then created an elapsed time table. We additionally created a feature set and 
metrics table that will be featured in chapter 5. 
4.2.3 Clinical Experiment Process. We retained only the columns containing the clinical 
data (features 12 – 38) which includes the questionnaire results and Amsel’s clinical criteria as 
mentioned previously. Feature selection and classification algorithms were applied to both giving 
us information on time elapsed and metric results. Tables were created from this output. 
4.2.4 Medical Experiment Process. We retained only the columns containing the 
medical data (features 39 – 418) which was derived from the data obtained via the 454 
sequencing of the V12 region of the 16S gene. We calculated the time taken for each feature 
selection and classification algorithm to produce output. We then created an elapsed time table 
and additionally created feature set and metrics tables. 
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4.2.5 Clean Full Experiment Process. We decided to address the issue of missing data 
for this set of experiments. We used a simple yet laborious process of “cleaning” the data. We 
examined the data in intervals of one week (days 1-7) at a time for each woman over the 10 week 
period. If data was missing for an entire week, we simply eliminated those rows. In instances 
where less than seven days of results were shown, we inserted rows to make a complete week. 
We then calculated the mean ( ) for each feature (column of data) within the week that was 
being examined: 
   
∑  
 
 
Where  is the mean, ∑   is the sum of data for the week being examined and   is the 
number of cells with data for the week being examined. We then inserted  into all of the cells 
with missing data in the column for the week being examined. This was repeated until the entire 
table was void of missing data. We then applied feature selection and classification algorithms 
giving time elapsed and metric results. We created tables using this output. 
4.2.6 Clean Clinical Experiment Process. We retained only the columns containing the 
now clean clinical data (features 12 – 38) which includes the questionnaire results and Amsel’s 
clinical criteria as mentioned previously. As with all previous experiments, feature selection and 
classification algorithms were applied to both giving us information on time elapsed and metric 
results. Tables were created from this output. 
4.2.7 Clean Medical Experiment Process. We retained only the columns containing the 
clean medical data (features 39 – 418) that included the added  data in addition to data 
obtained via the 454 sequencing of the V12 region of the 16S gene. We calculated the time taken 
for each feature selection and classification algorithm to produce output. We then created an 
elapsed time table and additionally created feature set and metrics tables. 
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4.3 Metrics Defined 
In classification where there are solely two classes such as with our data where yes = BV 
positive and no = BV negative, there are only four possible outcomes shown in Figure 5.  
 
Figure 5. Confusion Matrix. 
In the framework of our research, the confusion matrix components have the following 
descriptions:  
 True positive (TP) is the number of correctly classified positive cases of BV, 
 False negative (FN) is the number of positive cases of BV incorrectly classified as 
negative, 
 False positive (FP) is the number of negative cases of BV incorrectly classified as 
positive, and 
 True negative (TN) is the number of correctly classified negative cases of BV. 
The overall accuracy (AC) is the percentage of correctly classified cases of BV.  It is 
calculated using the number of correctly classified instances, TP and TN divided by the total 
number of classified BV cases: 
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The precision (PR) is the percentage of positive predictions retrieved that were actually 
positive cases of BV.  It is the number of true positives divided by the number of all retrieved 
positive results:  
    
  
     
 
The recall (RC) is the percentage of positive predictions retrieved from all positive cases 
of BV.  It is the number of true positives divided by the number of all positive cases of BV:  
    
  
     
 
The F-measure (FM) is the harmonic mean of precision and recall. The harmonic mean is 
usually used when determining the average of rates:  
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CHAPTER 5 
Experiments and Results 
In this chapter we present the results from our research that includes a variety of 
experiments performed on the raw full, time series removed, clinical only, medical only, cleaned 
full, cleaned clinical only and cleaned medical only datasets.  
5.1 Raw Full Dataset   
Table 6 displays the results of the feature selection process on the raw full dataset. Based 
solely on feature reduction, FS19 was the top ranking performer by reducing the features down 
to a feature set of 6. FS6 was the lowest ranking performer by only reducing the features down to 
a feature set of 183. 
Table 6 
Raw Full Feature Set 
Raw Full Feature Set 
Set Attribute 
Evaluator 
Search 
Method 
Classifier # of 
Feat. 
Selected Feature List 
F
FS1 
Cfs Subset 
Eval 
Best 
First 
 15 34, 105, 211, 262, 285, 320, 322, 338, 357, 
404, 411, 414, 416, 417, 418 
F
FS2 
Cfs Subset 
Eval 
Genetic 
Search 
 143 1, 2, 3, 6, 9, 14, 16, 18, 19, 23, 25, 26, 30, 
34, 35, 39, 49, 54, 63, 73, 82, 86, 88, 91, 
92, 93, 96, 99, 105, 122, 129, 131, 136, 
161, 167, 169, 173, 175, 178, 187, 188, 
195, 202, 209, 219, 226, 229, 230, 231, 
234, 236, 237, 238, 239, 240, 241, 243, 
244, 245, 247, 249, 250, 252, 256, 257, 
259, 261, 262, 263, 266, 269, 270, 271, 
272, 274, 275, 278, 279, 280, 281, 282, 
283, 284, 285, 289, 290, 293, 295, 299, 
305, 306, 308, 309, 310, 314, 320, 324, 
330, 331, 333, 337, 338, 339, 340, 345, 
346, 348, 349, 350, 352, 355, 357, 359, 
360, 362, 364, 366, 368, 370, 371, 374, 
376, 377, 382, 384, 385, 386, 389, 390, 
394, 395, 399, 403, 404, 405, 407, 409, 
410, 411, 413, 414, 416, 417 
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Table 6 
Cont. 
F
FS3 
Cfs 
SubsetEval 
RankSearch  16 34, 53, 105, 112, 211, 256, 262, 285, 
320, 327, 338, 404, 411, 414, 416, 417 
F
FS4 
Classifier 
SubsetEval 
Genetic 
Search 
OneR 99 3, 4, 6, 7, 8, 9, 11, 26, 28, 35, 38, 39, 
41, 48, 61, 62, 63, 64, 68, 72, 76, 77, 
80, 84, 92, 107, 111, 127, 129, 130, 
131, 137, 140, 165, 171, 172, 181, 
184, 186, 192, 199, 205, 206, 214, 
216, 217, 220, 227, 228, 230, 232, 
235, 243, 244, 250, 251, 258, 260, 
262, 263, 266, 275, 285, 286, 289, 
290, 291, 298, 301, 302, 303, 304, 
306, 313, 315, 323, 336, 337, 338, 
341, 343, 346, 348, 349, 351, 352, 
354, 359, 361, 363, 373, 378, 381, 
382, 397, 400, 409, 411, 415 
F
FS5 
Consistency 
SubsetEval 
BestFirst  9 2, 28, 33, 285, 411, 412, 414, 416, 418 
F
FS6 
Consistency 
SubsetEval 
Genetic 
Search 
 183 6, 8, 10, 11, 12, 14, 19, 22, 24, 27, 28, 
29, 30, 33, 36, 38, 39, 40, 42, 49, 51, 
55, 57, 60, 64, 66, 71, 76, 79, 81, 86, 
89, 92, 94, 95, 99, 100, 101, 105, 106, 
108, 110, 112, 113, 115, 116, 117, 
118, 122, 123, 125, 126, 127, 128, 
131, 136, 146, 147, 149, 150, 151, 
152, 159, 162, 163, 165, 167, 168, 
169, 170, 177, 178, 179, 182, 184, 
186, 187, 188, 195, 196, 197, 198, 
201, 205, 211, 217, 218, 219, 221, 
225, 226, 227, 231, 234, 236, 239, 
240, 243, 244, 245, 248, 249, 250, 
251, 258, 260, 261, 263, 266, 267, 
273, 275, 278, 279, 281, 282, 284, 
285, 288, 289, 293, 294, 295, 301, 
303, 309, 315, 316, 321, 324, 325, 
327, 329, 330, 332, 334, 339, 340, 
341, 342, 343, 345, 348, 349, 350, 
352, 354, 358, 360, 366, 367, 368, 
369, 371, 374, 376, 379, 380, 382, 
384, 386, 387, 388, 390, 392, 393, 
394, 395, 397, 398, 404, 405, 406, 
407, 409, 410, 411, 412, 413, 414, 
416, 417, 418 
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Table 6 
Cont. 
F
FS7 
Consistency 
SubsetEval 
Linear 
Forward 
Selection 
 13 7, 34, 49, 105, 122, 285, 320, 338, 
357, 411, 414, 416, 418 
F
FS8 
Consistency 
SubsetEval 
RankSearch  91 2, 7, 16, 20, 23, 25, 29, 30, 33, 34, 40, 
43, 49, 53, 63, 64, 87, 88, 91, 104, 
105, 112, 120, 122, 123, 124, 126, 
129, 135, 139, 145, 148, 157, 159, 
162, 163, 164, 171, 172, 191, 207, 
209, 211, 218, 226, 229, 230, 245, 
246, 248, 249, 250, 251, 254, 256, 
259, 262, 275, 279, 282, 285, 296, 
297, 298, 311, 318, 320, 321, 322, 
324, 325, 327, 334, 337, 338, 339, 
355, 357, 359, 375, 394, 400, 404, 
409, 411, 412, 413, 414, 416, 417, 418 
F
FS9 
Consistency 
SubsetEval 
Subset 
SizeForwar
dSelection 
 11 7, 34, 49, 105, 122, 285, 357, 411, 
414, 416, 418 
F
FS10 
iltered 
SubsetEval 
BestFirst  11 105, 285, 320, 338, 357, 404, 411, 
414, 416, 417, 418 
F
FS11 
ilteredS 
ubsetEval 
Genetic 
Search 
 143 1, 2, 3, 6, 9, 14, 16, 18, 19, 23, 25, 26, 
30, 34, 35, 39, 49, 54, 63, 73, 82, 86, 
88, 91, 92, 93, 96, 99, 105, 122, 129, 
131, 136, 161, 167, 169, 173, 175, 
178, 187, 188, 195, 202, 209, 219, 
226, 229, 230, 231, 234, 236, 237, 
238, 239, 240, 241, 243, 244, 245, 
247, 249, 250, 252, 256, 257, 259, 
261, 262, 263, 266, 269, 270, 271, 
272, 274, 275, 278, 279, 280, 281, 
282, 283, 284, 285, 289, 290, 293, 
295, 299, 305, 306, 308, 309, 310, 
314, 320, 324, 330, 331, 333, 337, 
338, 339, 340, 345, 346, 348, 349, 
350, 352, 355, 357, 359, 360, 362, 
364, 366, 368, 370, 371, 374, 376, 
377, 382, 384, 385, 386, 389, 390, 
394, 395, 399, 403, 404, 405, 407, 
409, 410, 411, 413, 414, 416, 417 
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Table 6 
Cont. 
F
FS12 
iltered 
SubsetEval 
RankSearch  8 256, 320, 327, 338, 404, 411, 414, 417 
F
FS13 
Wrapper 
SubsetEval 
BestFirst Naïve 
Bayes 
14 2, 7, 29, 33, 34, 104, 130, 228, 241, 
285, 295, 411, 416, 417 
F
FS14 
Wrapper 
SubsetEval 
BestFirst Bagging 7 1, 2, 3, 12, 201, 250, 411 
F
FS15 
Wrapper 
SubsetEval 
Genetic 
Search 
Bagging 156 1, 2, 3, 9, 12, 13, 18, 20, 21, 24, 25, 
28, 29, 30, 31, 32, 33, 34, 35, 36, 40, 
42, 43, 45, 46, 47, 49, 52, 53, 54, 56, 
59, 62, 63, 64, 65, 67, 69, 72, 77, 78, 
85, 89, 92, 93, 98, 100, 101, 103, 109, 
111, 114, 123, 127, 129, 130, 131, 
132, 136, 137, 142, 151, 153, 154, 
163, 165, 171, 172, 178, 181, 184, 
186, 187, 192, 199, 201, 205, 206, 
210, 214, 216, 217, 218, 220, 221, 
222, 229, 232, 235, 243, 244, 246, 
250, 251, 258, 260, 262, 263, 266, 
267, 270, 271, 273, 275, 280, 285, 
286, 288, 289, 290, 291, 293, 294, 
298, 301, 302, 306, 310, 313, 323, 
332, 338, 339, 342, 343, 347, 348, 
349, 351, 352, 354, 359, 361, 363, 
364, 371, 373, 378, 379, 383, 386, 
389, 393, 394, 397, 402, 403, 404, 
405, 409, 410, 412, 413, 416, 417, 418 
F
FS16 
Wrapper 
SubsetEval 
Greedy 
Stepwise 
Naïve 
Bayes 
14 2, 7, 29, 33, 34, 104, 130, 228, 241, 
285, 295, 411, 416, 417 
F
FS17 
Wrapper 
SubsetEval 
Linear 
Forward 
Selection 
Naïve 
Bayes 
9 34, 105, 285, 320, 334, 337, 338, 411, 
417 
F
FS18 
Wrapper 
SubsetEval 
RankSearch Naïve 
Bayes 
10 91, 104, 256, 320, 327, 338, 404, 411, 
414, 417 
F
FS19 
Wrapper 
SubsetEval 
Subset 
SizeForwar
dSelection 
Naïve 
Bayes 
6 105, 112, 285, 320, 411, 417 
F
FS20 
Wrapper 
SubsetEval 
Subset 
SizeForwar
dSelection 
Bagging 7 2, 91, 285, 296, 334, 404, 411 
 
  
 
 
 
Table 7 
Raw Full: Precision, Recall and F-Measure Rates 
Features Classifiers 
Name Metric A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 AC 96.3148% 95.6902% 96.2523% 96.0025% 96.1274% 96.7520% 96.5646% 96.6271% 97.0643% 
  PR 0.896 0.836 0.886 0.869 0.885 0.886 0.908 0.941 0.914 
  RC 0.863 0.9 0.871 0.876 0.863 0.908 0.867 0.835 0.896 
  FM 0.879 0.867 0.879 0.872 0.874 0.897 0.887 0.885 0.905 
FS2 AC 96.8145% 92.7545% 95.94% 94.6908% 96.4397% 97.0019% 97.0019% ERROR 96.6896% 
  PR 0.909 0.753 0.862 0.795 0.887 0.91 0.904   0.88 
  RC 0.884 0.795 0.88 0.888 0.884 0.896 0.904   0.912 
  FM 0.896 0.773 0.871 0.839 0.885 0.903 0.904   0.895 
FS3 AC 96.065% 95.94% 95.7527% 96.5646% 96.0025% 97.1268% 96.5646% 96.065% 96.8145% 
  PR 0.888 0.862 0.882 0.901 0.884 0.898 0.901 0.927 0.913 
  RC 0.855 0.88 0.839 0.876 0.855 0.92 0.876 0.811 0.88 
  FM 0.871 0.871 0.86 0.888 0.869 0.909 0.888 0.865 0.896 
FS4 AC 96.752% 91.5678% 96.3773% 93.8164% 95.8776% 95.94% 96.2523% ERROR 95.7527% 
  PR 0.909 0.75 0.89 0.793 0.865 0.862 0.883   0.847 
  RC 0.88 0.687 0.876 0.815 0.871 0.88 0.876   0.888 
  FM 0.894 0.717 0.883 0.804 0.868 0.871 0.879   0.867 
FS5 AC 96.5022% 95.8776% 96.1899% 95.3154% 95.8776% 96.9394% 96.877% 96.752% 97.1268% 
  PR 0.891 0.893 0.892 0.882 0.867 0.894 0.909 0.923 0.914 
  RC 0.884 0.835 0.859 0.807 0.867 0.912 0.888 0.863 0.9 
  FM 0.887 0.863 0.875 0.843 0.867 0.903 0.898 0.892 0.907 
FS6 AC 96.5022% 91.5678% 96.1274% 95.0031% 95.8151% 96.6271% 96.9394% ERROR 95.8151% 
  PR 0.897 0.721 0.87 0.812 0.87 0.888 0.92   0.853 
  RC 0.876 0.747 0.884 0.884 0.859 0.896 0.88   0.884 
  FM 0.886 0.734 0.876 0.846 0.865 0.892 0.899   0.868 40 
 
 
 
Table 7 
Cont. 
FS7 AC 96.1274% 96.3148% 96.1899% 96.3148% 96.1274% 95.7527% 96.752% 97.1268% 96.8145% 
  PR 0.885 0.871 0.873 0.88 0.888 0.866 0.902 0.947 0.899 
  RC 0.863 0.896 0.884 0.884 0.859 0.859 0.888 0.863 0.896 
  FM 0.874 0.883 0.878 0.882 0.873 0.863 0.895 0.903 0.897 
FS8 AC 96.752% 93.8788% 95.8151% 94.0037% 95.94% 97.1893% 96.877% 95.3779% 96.0025% 
  PR 0.912 0.796 0.855 0.772 0.877 0.902 0.916 0.903 0.86 
  RC 0.876 0.815 0.88 0.871 0.859 0.92 0.88 0.787 0.888 
  FM 0.893 0.806 0.867 0.819 0.868 0.911 0.898 0.841 0.874 
FS9 AC 96.1899% 95.6277% 96.1899% 95.5653% 96.1274% 97.1893% 96.752% 97.1268% 95.94% 
  PR 0.885 0.851 0.87 0.859 0.888 0.898 0.902 0.943 0.883 
  RC 0.867 0.871 0.888 0.855 0.859 0.924 0.888 0.867 0.851 
  FM 0.876 0.861 0.879 0.857 0.873 0.911 0.895 0.904 0.867 
FS10 AC 96.1274% 96.3148% 95.5653% 96.5022% 96.0025% 97.1893% 96.4397% 96.5646% 96.9394% 
  PR 0.888 0.886 0.871 0.897 0.878 0.905 0.897 0.937 0.91 
  RC 0.859 0.876 0.839 0.876 0.863 0.916 0.871 0.835 0.892 
  FM 0.873 0.881 0.855 0.886 0.87 0.91 0.884 0.883 0.901 
FS11 AC 96.8145% 92.7545% 95.94% 94.6908% 96.4397% 97.0019% 97.0019% ERROR 96.6896% 
  PR 0.909 0.753 0.862 0.795 0.887 0.91 0.904   0.88 
  RC 0.884 0.795 0.88 0.888 0.884 0.896 0.904   0.912 
  FM 0.896 0.773 0.871 0.839 0.885 0.903 0.904   0.895 
FS12 AC 96.065% 95.94% 95.6902% 96.1899% 95.8776% 95.253% 95.7527% 95.5653% 96.4397% 
  PR 0.904 0.883 0.913 0.912 0.865 0.847 0.866 0.964 0.94 
  RC 0.835 0.851 0.799 0.835 0.871 0.847 0.859 0.743 0.823 
  FM 0.868 0.867 0.852 0.872 0.868 0.847 0.863 0.839 0.878 
FS13 AC 96.9394% 96.5022% 96.3773% 97.3766% 96.1899% 97.1268% 96.9394% 97.3142% 97.3766% 
  PR 0.913 0.881 0.875 0.916 0.885 0.901 0.907 0.936 0.912 
  RC 0.888 0.896 0.896 0.916 0.867 0.916 0.896 0.888 0.92 
  FM 0.9 0.888 0.885 0.916 0.876 0.908 0.901 0.911 0.916 41 
 
 
 
Table 7 
Cont.  
FS14 AC 96.6896% 95.6902% 96.5022% 95.4403% 95.8776% 96.9394% 96.0025% 96.877% 95.7527% 
  PR 0.908 0.866 0.9 0.846 0.865 0.907 0.871 0.934 0.876 
  RC 0.876 0.855 0.871 0.863 0.871 0.896 0.871 0.859 0.847 
  FM 0.892 0.861 0.886 0.855 0.868 0.901 0.871 0.895 0.861 
FS15 AC 96.752% 91.8176% 95.3779% 93.6914% 96.6896% 97.5016% 96.5022% ERROR 95.8151% 
  PR 0.896 0.746 0.849 0.803 0.938 0.927 0.921   0.855 
  RC 0.896 0.719 0.855 0.787 0.843 0.912 0.847   0.88 
  FM 0.896 0.732 0.852 0.795 0.888 0.919 0.883   0.867 
FS16 AC 96.9394% 96.5022% 96.3773% 97.3766% 96.1899% 97.1268% 96.9394% 97.3142% 97.3766% 
  PR 0.913 0.881 0.875 0.916 0.885 0.901 0.907 0.936 0.912 
  RC 0.888 0.896 0.896 0.916 0.867 0.916 0.896 0.888 0.92 
  FM 0.9 0.888 0.885 0.916 0.876 0.908 0.901 0.911 0.916 
FS17 AC 96.4397% 96.1274% 96.3773% 96.9394% 95.8776% 95.6902% 95.8151% 94.6908% 96.5022% 
  PR 0.925 0.858 0.896 0.917 0.865 0.844 0.873 0.941 0.897 
  RC 0.839 0.9 0.867 0.884 0.871 0.888 0.855 0.703 0.876 
  FM 0.88 0.878 0.882 0.9 0.868 0.865 0.864 0.805 0.886 
FS18 AC 96.0650% 95.94% 95.6902% 96.3148% 95.8776% 95.5028% 95.7527% 95.4403% 96.4397% 
  PR 0.904 0.883 0.913 0.924 0.865 0.858 0.866 0.963 0.94 
  RC 0.835 0.851 0.799 0.831 0.871 0.851 0.859 0.735 0.823 
  FM 0.868 0.867 0.852 0.875 0.868 0.855 0.863 0.834 0.878 
FS19 AC 96.2523% 96.3148% 95.6277% 96.9394% 95.94% 95.7527% 96.1274% 94.6284% 96.3148% 
  PR 0.913 0.871 0.891 0.917 0.865 0.847 0.879 0.95 0.906 
  RC 0.839 0.896 0.819 0.884 0.876 0.888 0.871 0.691 0.851 
  FM 0.874 0.883 0.854 0.9 0.87 0.867 0.875 0.8 0.878 
FS20 AC 96.6896% 95.8776% 96.5022% 95.0656% 95.8776% 96.2523% 96.065% 96.1274% 96.5022% 
  PR 0.912 0.907 0.9 0.866 0.865 0.874 0.872 0.935 0.907 
  RC 0.871 0.819 0.871 0.807 0.871 0.888 0.876 0.807 0.863 
  FM 0.891 0.861 0.886 0.836 0.868 0.88 0.874 0.866 0.885 42 
43 
 
 
Table 7 exhibits the results of the classification process on the raw full dataset. We 
calculated the accuracy (AC), precision (PR), recall (RC) and F-measure (FM). FS15 A6 
(97.5016%) ranked highest in accuracy, FS12 A8 (0.964) in precision FS9 A6 (0.924) for recall 
and FS15 A6 for F-Measure (0.919). Based solely on AC and FM, FS15 A6 is the top ranking 
performer.  
 The raw full time elapsed table featured in Table 8 shows that based on the sum of the 
time elapsed for feature selection and classification, FS9 (0:00:21) had the best performance and 
FS15(1:17:02) had the poorest performance. 
Table 8 
Raw Full Time Elapsed 
Features Classifiers (Time Elapsed) 
Name Time A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 0:00:01 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:02 0:00:15 0:00:03 
FS2 0:00:10 0:00:06 0:00:04 0:00:04 0:00:02 0:00:09 0:00:04 0:00:20 0:01:33 0:00:12 
FS3 0:00:11 0:00:00 0:00:01 0:00:00 0:00:01 0:00:01 0:00:01 0:00:02 0:00:12 0:00:02 
FS4 0:00:11 0:00:03 0:00:02 0:00:03 0:00:01 0:00:07 0:00:04 0:00:14 0:00:49 0:00:12 
FS5 0:00:05 0:00:00 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:12 0:00:01 
FS6 0:00:02 0:00:07 0:00:04 0:00:05 0:00:01 0:00:13 0:00:04 0:00:24 0:01:43 0:00:16 
FS7 0:00:02 0:00:00 0:00:01 0:00:01 0:00:00 0:00:01 0:00:00 0:00:02 0:00:13 0:00:02 
FS8 0:00:03 0:00:03 0:00:02 0:00:03 0:00:01 0:00:06 0:00:02 0:00:13 0:00:47 0:00:08 
FS9 0:00:02 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:13 0:00:02 
FS10 0:00:01 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:02 0:00:02 0:00:13 0:00:01 
FS11 0:00:10 0:00:05 0:00:04 0:00:04 0:00:01 0:00:10 0:00:03 0:00:19 0:01:31 0:00:11 
FS12 0:00:11 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:07 0:00:01 
FS13 0:17:07 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:11 0:00:02 
FS14 0:29:54 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:06 0:00:02 
FS15 1:14:25 0:00:06 0:00:04 0:00:06 0:00:01 0:00:11 0:00:04 0:00:21 0:01:31 0:00:13 
FS16 0:11:37 0:00:00 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:11 0:00:02 
FS17 0:00:54 0:00:00 0:00:01 0:00:00 0:00:00 0:00:01 0:00:02 0:00:01 0:00:05 0:00:01 
FS18 0:17:05 0:00:00 0:00:01 0:00:01 0:00:00 0:00:01 0:00:02 0:00:02 0:00:07 0:00:01 
FS19 0:00:24 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:05 0:00:02 
FS20 0:02:25 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:05 0:00:02 
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When considering runtime, reduction in features and recall in Figure 6 below, we have 
determined that FS16 A9 is the better algorithm to use for this dataset. 
       
Figure 6. Top Three Raw Full Set. 
5.2 Time Series Removed Dataset   
Table 9 displays the results of the feature selection process on time series dataset. Based 
solely on feature reduction, FS14, FS19 and FS20 were the top ranking performers by reducing 
the features down to a feature set of 6. FS15 was the lowest ranking performer by only reducing 
the features down to a feature set of 219. 
Table 9 
Time Series Removed Feature Set 
Time Series Removed  Dataset 
Set Attribute  
Evaluator 
Search  
Method 
CL # of 
Feat. 
Selected Feature List 
FS1 Cfs Subset 
Eval 
BestFirst  15 34, 105, 211, 262, 285, 320, 322, 
338, 357, 404, 411, 414, 416, 417, 
418 
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FS2 Cfs Subset 
Eval 
Genetic 
Search 
 141 14, 16, 18, 20, 21, 26, 28, 29, 34, 
35, 37, 38, 42, 45, 49, 51, 52, 55, 
56, 60, 74, 75, 79, 81, 83, 87, 91, 
104, 109, 112, 114, 115, 117, 121, 
122, 125, 126, 127, 129, 132, 138, 
141, 145, 148, 157, 160, 161, 162, 
163, 167, 172, 179, 183, 188, 198, 
199, 200, 204, 210, 214, 221, 222, 
230, 233, 235, 238, 247, 253, 256, 
257, 259, 262, 268, 269, 270, 275, 
276, 278, 279, 281, 282, 283, 284, 
285, 287, 288, 294, 298, 299, 300, 
301, 307, 308, 309, 310, 312, 314, 
318, 319, 320, 321, 324, 325, 327, 
328, 329, 334, 339, 340, 342, 345, 
349, 353, 355, 357, 358, 359, 362, 
363, 364, 365, 371, 373, 383, 395, 
397, 401, 402, 404, 405, 406, 407, 
408, 409, 411, 413, 414, 415, 416, 
417, 418 
FS3 Cfs 
SubsetEval 
RankSearch  16 34, 53, 105, 112, 211, 256, 262, 
285, 320, 327, 338, 404, 411, 414, 
416, 417 
FS4 Classifier 
SubsetEval 
Genetic 
Search 
OneR 116 13, 15, 17, 29, 33, 34, 38, 39, 43, 
44, 49, 51, 52, 57, 61, 66, 68, 69, 
81, 88, 91, 96, 99, 101, 102, 104, 
108, 112, 113, 121, 124, 125, 134, 
135, 138, 141, 155, 157, 161, 164, 
174, 175, 182, 183, 184, 188, 191, 
196, 202, 206, 211, 212, 214, 216, 
217, 218, 220, 221, 222, 233, 234, 
238, 242, 243, 247, 251, 253, 254, 
262, 264, 270, 274, 279, 282, 284, 
286, 287, 290, 291, 292, 297, 299, 
301, 305, 309, 310, 311, 314, 315, 
318, 320, 324, 325, 329, 336, 339, 
342, 343, 346, 349, 358, 363, 365, 
368, 371, 373, 387, 393, 397, 400, 
402, 404, 405, 411, 416, 418 
FS5 Consistency 
SubsetEval 
BestFirst  9 28, 33, 285, 411, 413, 414, 416, 
417, 418 
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FS6 Consistency 
SubsetEval 
Genetic 
Search 
 182 12, 14, 16, 18, 20, 23, 25, 26, 27, 
28, 29, 30, 31, 33, 34, 36, 37, 45, 
49, 51, 52, 53, 55, 56, 61, 62, 69, 
71, 72, 76, 78, 80, 83, 85, 86, 89, 
96, 98, 101, 105, 107, 108, 110, 
111, 114, 115, 117, 120, 121, 123, 
125, 126, 127, 131, 132, 134, 137, 
139, 144, 145, 146, 149, 151, 153, 
154, 156, 157, 158, 160, 162, 164, 
166, 168, 170, 173, 174, 175, 176, 
183, 186, 188, 193, 195, 204, 207, 
209, 210, 212, 213, 216, 218, 221, 
223, 226, 228, 231, 232, 235, 236, 
238, 240, 241, 247, 248, 250, 253, 
255, 256, 258, 259, 261, 263, 265, 
267, 270, 271, 272, 274, 276, 277, 
279, 282, 285, 286, 288, 292, 293, 
299, 301, 304, 305, 307, 312, 315, 
318, 321, 324, 325, 328, 329, 332, 
333, 336, 338, 341, 342, 343, 344, 
347, 349, 351, 352, 355, 357, 358, 
359, 360, 361, 362, 363, 364, 365, 
368, 369, 370, 371, 374, 381, 384, 
388, 392, 394, 402, 404, 405, 407, 
408, 409, 411, 413, 416, 418 
FS7 Consistency 
SubsetEval 
Linear 
Forward 
Selection 
 13 34, 49, 105, 122, 285, 320, 338, 
357, 411, 414, 416, 417, 418 
FS8 Consistency 
SubsetEval 
RankSearch  89 16, 20, 23, 25, 29, 30, 33, 34, 40, 
43, 49, 53, 63, 64, 87, 88, 91, 104, 
105, 112, 120, 122, 123, 124, 126, 
129, 135, 139, 145, 148, 157, 159, 
162, 163, 164, 171, 172, 191, 207, 
209, 211, 218, 226, 229, 230, 245, 
246, 248, 249, 250, 251, 254, 256, 
259, 262, 275, 279, 282, 285, 296, 
297, 298, 311, 318, 320, 321, 322, 
324, 325, 327, 334, 337, 338, 339, 
355, 357, 359, 375, 394, 400, 404, 
409, 411, 412, 413, 414, 416, 417, 
418 
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FS9 Consistency 
SubsetEval 
Subset 
SizeForward
Selection 
 11 34, 49, 105, 122, 285, 357, 411, 
414, 416, 417, 418 
FS10 Filtered 
SubsetEval 
BestFirst  11 105, 285, 320, 338, 357, 404, 411, 
414, 416, 417, 418 
FS11 FilteredS 
ubsetEval 
Genetic 
Search 
 141 14, 16, 18, 20, 21, 26, 28, 29, 34, 
35, 37, 38, 42, 45, 49, 51, 52, 55, 
56, 60, 74, 75, 79, 81, 83, 87, 91, 
104, 109, 112, 114, 115, 117, 121, 
122, 125, 126, 127, 129, 132, 138, 
141, 145, 148, 157, 160, 161, 162, 
163, 167, 172, 179, 183, 188, 198, 
199, 200, 204, 210, 214, 221, 222, 
230, 233, 235, 238, 247, 253, 256, 
257, 259, 262, 268, 269, 270, 275, 
276, 278, 279, 281, 282, 283, 284, 
285, 287, 288, 294, 298, 299, 300, 
301, 307, 308, 309, 310, 312, 314, 
318, 319, 320, 321, 324, 325, 327, 
328, 329, 334, 339, 340, 342, 345, 
349, 353, 355, 357, 358, 359, 362, 
363, 364, 365, 371, 373, 383, 395, 
397, 401, 402, 404, 405, 406, 407, 
408, 409, 411, 413, 414, 415, 416, 
417, 418 
FS12 Filtered 
SubsetEval 
RankSearch  8 256, 320, 327, 338, 404, 411, 414, 
417 
FS13 Wrapper 
SubsetEval 
BestFirst Naïve 
Bayes 
12 34, 41, 130, 131, 167, 228, 241, 
285, 295, 411, 416, 417 
FS14 Wrapper 
SubsetEval 
BestFirst Bagging 6 126, 137, 139, 402, 411, 413 
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FS15 Wrapper 
SubsetEval 
Genetic 
Search 
Bagging 219 12, 14, 15, 16, 18, 19, 20, 23, 25, 29, 
30, 31, 32, 33, 34, 36, 37, 39, 40, 42, 
44, 45, 46, 50, 53, 55, 56, 58, 59, 60, 
62, 63, 65, 66, 68, 71, 72, 75, 76, 80, 
81, 83, 88, 89, 96, 98, 99, 103, 106, 
107, 108, 109, 111, 113, 114, 115, 116, 
117, 119, 120, 122, 124, 125, 128, 130, 
131, 132, 133, 139, 140, 145, 147, 148, 
154, 155, 156, 157, 159, 160, 165, 167, 
168, 170, 171, 172, 174, 176, 177, 178, 
180, 183, 185, 186, 187, 188, 190, 191, 
194, 195, 197, 199, 201, 202, 203, 204, 
206, 207, 208, 209, 210, 214, 217, 220, 
221, 222, 223, 224, 225, 226, 228, 230, 
231, 232, 233, 234, 235, 236, 237, 240, 
242, 243, 244, 248, 250, 251, 253, 254, 
255, 257, 258, 262, 263, 265, 266, 268, 
270, 275, 277, 278, 279, 283, 284, 285, 
286, 293, 294, 296, 298, 300, 302, 304, 
306, 309, 310, 312, 316, 321, 322, 325, 
327, 328, 329, 330, 332, 333, 334, 336, 
338, 339, 340, 344, 347, 348, 350, 353, 
354, 355, 357, 358, 360, 361, 362, 363, 
364, 365, 367, 369, 371, 374, 376, 384, 
386, 390, 391, 392, 394, 396, 398, 401, 
402, 404, 407, 408, 410, 411, 413, 415, 
416, 417 
FS16 Wrapper 
SubsetEval 
Greedy 
Stepwise 
Naïve 
Bayes 
12 34, 41, 130, 131, 167, 228, 241, 285, 
295, 411, 416, 417 
FS17 Wrapper 
SubsetEval 
Linear 
Forward 
Selection 
Naïve 
Bayes 
9 34, 105, 285, 320, 334, 337, 338, 411, 
417 
FS18 Wrapper 
SubsetEval 
Rank 
Search 
Naïve 
Bayes 
10 91, 104, 256, 320, 327, 338, 404, 411, 
414, 417 
FS19 Wrapper 
SubsetEval 
Subset 
SizeForwar
dSelection 
Naïve 
Bayes 
6 105, 112, 285, 320, 411, 417 
FS20 Wrapper 
SubsetEval 
Subset 
SizeForwar
dSelection 
Bagging 6 285, 357, 409, 411, 416, 417 
 
 
 
 
Table 10 
Time Series Removed: Precision, Recall and F-Measure Rates 
Features Classifiers 
Name Metric A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 AC 96.3148% 95.6902% 96.2523% 96.0025% 96.1274% 96.7520% 96.5646% 96.6271% 97.0643% 
  PR 0.896 0.836 0.886 0.869 0.885 0.886 0.908 0.941 0.914 
  RC 0.863 0.9 0.871 0.876 0.863 0.908 0.867 0.835 0.896 
  FM 0.879 0.867 0.879 0.872 0.874 0.897 0.887 0.885 0.905 
FS2 AC 97.0643% 92.5671% 96.065% 94.8157% 96.0025% 97.1268% 96.6271% ERROR 96.5022% 
  PR 0.924 0.769 0.875 0.824 0.878 0.904 0.905   0.875 
  RC 0.884 0.747 0.871 0.847 0.863 0.912 0.876   0.904 
  FM 0.903 0.758 0.873 0.836 0.87 0.908 0.89   0.889 
FS3 AC 96.065% 95.94% 95.7527% 96.5646% 96.0025% 97.1268% 96.5646% 96.065% 96.8145% 
  PR 0.888 0.862 0.882 0.901 0.884 0.898 0.901 0.927 0.913 
  RC 0.855 0.88 0.839 0.876 0.855 0.92 0.876 0.811 0.88 
  FM 0.871 0.871 0.86 0.888 0.869 0.909 0.888 0.865 0.896 
FS4 AC 97.0019% 92.2548% 96.5022% 94.3161% 96.0025% 96.752% 96.877% ERROR 96.2523% 
  PR 0.914 0.78 0.9 0.816 0.874 0.886 0.92   0.851 
  RC 0.892 0.699 0.871 0.819 0.867 0.908 0.876   0.92 
  FM 0.902 0.737 0.886 0.818 0.871 0.897 0.897   0.884 
FS5 AC 96.6896% 96.1274% 96.3148% 96.3773% 96.065% 97.1268% 96.8145% 96.6271% 95.94% 
  PR 0.905 0.888 0.896 0.893 0.878 0.889 0.919 0.908 0.88 
  RC 0.88 0.859 0.863 0.871 0.867 0.932 0.871 0.871 0.855 
  FM 0.892 0.873 0.879 0.882 0.873 0.91 0.895 0.889 0.868 
FS6 AC 97.1268% 85.8214% 96.1899% 94.5659% 96.0025% 96.6271% 96.9394% ERROR 95.6277% 
  PR 0.911 0.615 0.879 0.793 0.874 0.888 0.917   0.871 
  RC 0.904 0.237 0.876 0.88 0.867 0.896 0.884   0.843 
  FM 0.907 0.342 0.877 0.834 0.871 0.892 0.9   0.857 49 
 
 
 
Table 10 
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FS7 AC 96.4397% 96.0025% 96.1899% 96.4397% 96.1274% 96.9394% 96.5646% 96.9394% 96.3148% 
  PR 0.897 0.849 0.882 0.884 0.885 0.894 0.908 0.946 0.889 
  RC 0.871 0.904 0.871 0.888 0.863 0.912 0.867 0.851 0.871 
  FM 0.884 0.875 0.877 0.886 0.874 0.903 0.887 0.896 0.88 
FS8 AC 96.5022% 93.8788% 95.6902% 94.0037% 95.94% 97.1893% 96.9394% 95.0031% 96.0025% 
  PR 0.9 0.794 0.854 0.772 0.877 0.908 0.92 0.904 0.866 
  RC 0.871 0.819 0.871 0.871 0.859 0.912 0.88 0.759 0.88 
  FM 0.886 0.806 0.863 0.819 0.868 0.91 0.899 0.825 0.873 
FS9 AC 96.4397% 95.6902% 95.94% 96.065% 96.1274% 97.1268% 96.5646% 96.8145% 96.1899% 
  PR 0.897 0.833 0.874 0.866 0.885 0.901 0.908 0.942 0.87 
  RC 0.871 0.904 0.863 0.884 0.863 0.916 0.867 0.847 0.888 
  FM 0.884 0.867 0.869 0.875 0.874 0.908 0.887 0.892 0.879 
FS10 AC 96.1274% 96.3148% 95.5653% 96.5022% 96.0025% 97.1893% 96.4397% 96.5646% 96.9394% 
  PR 0.888 0.886 0.871 0.897 0.878 0.905 0.897 0.937 0.91 
  RC 0.859 0.876 0.839 0.876 0.863 0.916 0.871 0.835 0.892 
  FM 0.873 0.881 0.855 0.886 0.87 0.91 0.884 0.883 0.901 
FS11 AC 97.0643% 92.5671% 96.065% 94.8157% 96.0025% 97.1268% 96.6271% ERROR 96.5022% 
  PR 0.924 0.769 0.875 0.824 0.878 0.904 0.905   0.875 
  RC 0.884 0.747 0.871 0.847 0.863 0.912 0.876   0.904 
  FM 0.903 0.758 0.873 0.836 0.87 0.908 0.89   0.889 
FS12 AC 96.065% 95.94% 95.6902% 96.1899% 95.8776% 95.253% 95.7527% 95.5653% 96.4397% 
  PR 0.904 0.883 0.913 0.912 0.865 0.847 0.866 0.964 0.94 
  RC 0.835 0.851 0.799 0.835 0.871 0.847 0.859 0.743 0.823 
  FM 0.868 0.867 0.852 0.872 0.868 0.847 0.863 0.839 0.878 
FS13 AC 96.4397% 96.1274% 96.1274% 97.1893% 95.94% 97.1268% 96.6896% 96.3773% 96.8145% 
  PR 0.9 0.858 0.858 0.895 0.88 0.904 0.905 0.948 0.906 
  RC 0.867 0.9 0.9 0.928 0.855 0.912 0.88 0.811 0.888 
  FM 0.883 0.878 0.878 0.911 0.868 0.908 0.892 0.874 0.897 50 
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FS14 AC 96.6271% 93.8164% 96.4397% 94.8157% 95.8776% 96.5646% 96.4397% 93.5665% 96.1899% 
  PR 0.911 0.841 0.907 0.84 0.865 0.891 0.897 0.94 0.92 
  RC 0.867 0.743 0.859 0.823 0.871 0.888 0.871 0.627 0.827 
  FM 0.889 0.789 0.882 0.832 0.868 0.889 0.884 0.752 0.871 
FS15 AC 97.0019% 85.3217% 96.1274% 93.7539% 96.065% 97.1268% 96.8145% ERROR 95.3779% 
  PR 0.91 0.576 0.867 0.773 0.878 0.908 0.913   0.83 
  RC 0.896 0.213 0.888 0.847 0.867 0.908 0.88   0.884 
  FM 0.903 0.311 0.877 0.808 0.873 0.908 0.896   0.856 
FS16 AC 96.4397% 96.1274% 96.1274% 97.1893% 95.94% 97.1268% 96.6896% 96.3773% 96.8145% 
  PR 0.9 0.858 0.858 0.895 0.88 0.904 0.905 0.948 0.906 
  RC 0.867 0.9 0.9 0.928 0.855 0.912 0.88 0.811 0.888 
  FM 0.883 0.878 0.878 0.911 0.868 0.908 0.892 0.874 0.897 
FS17 AC 96.4397% 96.1274% 96.3773% 96.9394% 95.8776% 95.6902% 95.8151% 94.6908% 96.5022% 
  PR 0.925 0.858 0.896 0.917 0.865 0.844 0.873 0.941 0.897 
  RC 0.839 0.9 0.867 0.884 0.871 0.888 0.855 0.703 0.876 
  FM 0.88 0.878 0.882 0.9 0.868 0.865 0.864 0.805 0.886 
FS18 AC 96.0650% 95.94% 95.6902% 96.3148% 95.8776% 95.5028% 95.7527% 95.4403% 96.4397% 
  PR 0.904 0.883 0.913 0.924 0.865 0.858 0.866 0.963 0.94 
  RC 0.835 0.851 0.799 0.831 0.871 0.851 0.859 0.735 0.823 
  FM 0.868 0.867 0.852 0.875 0.868 0.855 0.863 0.834 0.878 
FS19 AC 96.2523% 96.3148% 95.6277% 96.9394% 95.94% 95.7527% 96.1274% 94.6284% 96.3148% 
  PR 0.913 0.871 0.891 0.917 0.865 0.847 0.879 0.95 0.906 
  RC 0.839 0.896 0.819 0.884 0.876 0.888 0.871 0.691 0.851 
  FM 0.874 0.883 0.854 0.9 0.87 0.867 0.875 0.8 0.878 
FS20 AC 96.3773% 95.8151% 95.94% 95.8151% 95.8151% 96.5022% 96.4397% 95.8151% 96.4397% 
  PR 0.893 0.87 0.88 0.87 0.873 0.878 0.9 0.938 0.921 
  RC 0.871 0.859 0.855 0.859 0.855 0.9 0.867 0.783 0.843 
  FM 0.882 0.865 0.868 0.865 0.864 0.889 0.883 0.853 0.881 51 
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Table 10 exhibits the results of the classification process on the time series removed 
dataset. We calculated the accuracy (AC), precision (PR), recall (RC) and F-measure (FM). FS10 
A6, FS13 A4 and FS16 A4 (97.1893%) ranked highest in accuracy, FS12 A8 (0.964) in precision 
FS5 A6 (0.932) for recall and FS13 A4 and FS16 A4 for F-Measure (0.911). Based solely on AC 
and FM, FS13 A4 and FS16 A4 are the top ranking performers.  
The raw full time elapsed table featured in Table 11 shows that based on the sum of the 
time elapsed for feature selection and classification, FS9, FS10 and FS12 (0:00:23) had the best 
performance and FS15 (1:18:57) had the poorest performance. 
Table 11 
Time Series Removed Time Elapsed 
FEATURES CLASSIFIERS (TIME ELAPSED) 
Name Time A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 0:00:07 0:00:00 0:00:01 0:00:00 0:00:00 0:00:02 0:00:01 0:00:03 0:00:15 0:00:02 
FS2 0:00:11 0:00:04 0:00:03 0:00:07 0:00:02 0:00:00 0:00:05 0:00:21 0:01:39 0:00:16 
FS3 0:00:10 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:03 0:00:13 0:00:02 
FS4 0:00:43 0:00:04 0:00:03 0:00:04 0:00:01 0:00:09 0:00:04 0:00:17 0:01:13 0:00:10 
FS5 0:00:05 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:01 0:00:16 0:00:01 
FS6 0:00:03 0:00:06 0:00:04 0:00:05 0:00:02 0:00:14 0:00:05 0:00:27 0:01:44 0:00:18 
FS7 0:00:02 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:02 0:00:02 0:00:14 0:00:02 
FS8 0:00:03 0:00:03 0:00:03 0:00:03 0:00:01 0:00:06 0:00:03 0:00:13 0:00:48 0:00:08 
FS9 0:00:02 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:02 0:00:13 0:00:01 
FS10 0:00:02 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:02 0:00:02 0:00:14 0:00:01 
FS11 0:00:10 0:00:09 0:00:03 0:00:07 0:00:02 0:00:12 0:00:06 0:00:23 0:01:39 0:00:24 
FS12 0:00:10 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:08 0:00:02 
FS13 0:12:17 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:10 0:00:01 
FS14 0:24:05 0:00:01 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:08 0:00:01 
FS15 1:15:16 0:00:07 0:00:05 0:00:09 0:00:02 0:00:17 0:00:06 0:00:31 0:01:59 0:00:25 
FS16 0:07:48 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:02 0:00:12 0:00:01 
FS17 0:01:02 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:02 0:00:01 0:00:06 0:00:02 
FS18 0:12:49 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:08 0:00:01 
FS19 0:00:24 0:00:00 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:05 0:00:01 
FS20 0:01:57 0:00:00 0:00:00 0:00:01 0:00:00 0:00:01 0:00:01 0:00:01 0:00:08 0:00:01 
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When considering runtime, reduction in features and recall in Figure 7 below, we have 
determined that FS16 A4 is the better algorithm to use for this dataset.  
 
 
Figure 7. Top Three Time Series Removed. 
5.3 Clinical Dataset   
Table 12 displays the results of the feature selection process on the clinical dataset. Based 
solely on feature reduction, FS13, FS16, FS17 and FS19 were the top ranking performers by 
reducing the features down to a feature set of 2. FS15 was the lowest ranking performer by only 
reducing the features down to a feature set of 19.  
Table 12 
Clinical Feature Set 
Clinical  Feature Set 
Set Attribute  
Evaluator 
Search  
Method 
Classifier # of 
Feat. 
Selected Feature List 
FS1 Cfs Subset 
Eval 
BestFirst  6 20, 21, 25, 29, 33, 34 
FS2 Cfs Subset 
Eval 
Genetic 
Search 
 6 20, 21, 25, 29, 33, 34 
FS3 Cfs 
SubsetEval 
RankSearch  7 20, 21, 23, 25, 29, 33, 34 
FS4 Classifier 
SubsetEval 
Genetic 
Search 
OneR 5 13, 14, 24, 27, 34 
FS5 Consistency 
SubsetEval 
BestFirst  10 20, 21, 23, 25, 28, 29, 30, 33, 34, 38 
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FS6 Consistency 
SubsetEval 
Genetic 
Search 
 13 18, 20, 21, 23, 25, 28, 29, 30, 31, 
33, 34, 37, 38 
FS7 Consistency 
SubsetEval 
Linear 
Forward 
Selection 
 10 20, 21, 23, 25, 28, 29, 30, 33, 34, 38 
FS8 Consistency 
SubsetEval 
RankSearch  11 16, 20, 21, 23, 25, 28, 29, 30, 33, 
34, 38 
FS9 Consistency 
SubsetEval 
Subset 
SizeForward
Selection 
 10 20, 21, 23, 25, 28, 29, 30, 33, 34, 38 
FS10 Filtered 
SubsetEval 
BestFirst  3 29, 33, 34 
FS11 FilteredS 
ubsetEval 
Genetic 
Search 
 3 29, 33, 34 
FS12 Filtered 
SubsetEval 
RankSearch  5 23, 25, 29, 33, 34 
FS13 Wrapper 
SubsetEval 
BestFirst Naïve 
Bayes 
2 20, 34 
FS14 Wrapper 
SubsetEval 
BestFirst Bagging 10 12, 13, 20, 25, 29, 30, 32, 33, 34, 37 
FS15 Wrapper 
SubsetEval 
Genetic 
Search 
Bagging 19 12, 13, 16, 19, 20, 23, 25, 26, 27, 
28, 29, 31, 32, 33, 34, 35, 36, 37, 38 
FS16 Wrapper 
SubsetEval 
Greedy 
Stepwise 
Naïve 
Bayes 
2 20, 34 
FS17 Wrapper 
SubsetEval 
Linear 
Forward 
Selection 
Naïve 
Bayes 
2 20, 34 
FS18 Wrapper 
SubsetEval 
RankSearch Naïve 
Bayes 
6 16, 23, 25, 29, 33, 34 
FS19 Wrapper 
SubsetEval 
Subset 
SizeForward
Selection 
Naïve 
Bayes 
2 20, 34 
FS20 Wrapper 
SubsetEval 
Subset 
SizeForward
Selection 
Bagging 10 12, 13, 20, 25, 29, 30, 32, 33, 34, 37 
 
 
 
 
Table 13 
Clinical: Precision, Recall and F-Measure Rates 
Features Classifiers 
Name Metric A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 AC 88.0075% 86.1961% 87.6327% 84.5721% 86.3835% 88.1949% 87.0081% 88.3823% 88.1949% 
  PR 0.699 0.646 0.701 0.506 0.746 0.727 0.652 0.899 0.727 
  RC 0.402 0.249 0.357 0.325 0.189 0.386 0.353 0.285 0.386 
  FM 0.51 0.359 0.473 0.396 0.301 0.504 0.458 0.433 0.504 
FS2 AC 88.0075% 86.1961% 87.6327% 84.5721% 86.3835% 88.1949% 87.0081% 88.3823% 88.1949% 
  PR 0.699 0.646 0.701 0.506 0.746 0.727 0.652 0.899 0.727 
  RC 0.402 0.249 0.357 0.325 0.189 0.386 0.353 0.285 0.386 
  FM 0.51 0.359 0.473 0.396 0.301 0.504 0.458 0.433 0.504 
FS3 AC 88.0075% 86.8207% 87.5703% 84.6971% 86.3835% 88.4447% 86.8207% 88.3198% 87.8826% 
  PR 0.697 0.707 0.695 0.512 0.746 0.746 0.664 0.897 0.72 
  RC 0.406 0.261 0.357 0.333 0.189 0.39 0.309 0.281 0.361 
  FM 0.513 0.381 0.472 0.404 0.301 0.512 0.422 0.428 0.481 
FS4 AC 86.0712% 86.0712% 85.8838% 86.1337% 86.1337% 86.0087% 86.1337% 84.4472% 86.0087% 
  PR 0.75 0.75 0.745 0.737 0.737 0.766 0.737 0 0.727 
  RC 0.157 0.157 0.141 0.169 0.169 0.145 0.169 0 0.161 
  FM 0.259 0.259 0.236 0.275 0.275 0.243 0.275 0 0.263 
FS5 AC 88.9444% 86.5084% 87.7577% 82.6359% 86.1337% 88.8819% 87.4453% 88.6321% 87.5703% 
  PR 0.737 0.657 0.669 0.435 0.574 0.698 0.64 0.838 0.667 
  RC 0.45 0.277 0.422 0.39 0.422 0.502 0.442 0.333 0.402 
  FM 0.559 0.39 0.517 0.411 0.486 0.584 0.523 0.477 0.501 
FS6 AC 88.9444% 86.321% 88.1324% 83.0106% 86.1337% 88.6946% 87.4453% 88.9444% 87.8201% 
  PR 0.747 0.653 0.681 0.447 0.574 0.683 0.64 0.867 0.669 
  RC 0.438 0.257 0.446 0.386 0.422 0.51 0.442 0.341 0.43 
  FM 0.552 0.369 0.539 0.414 0.486 0.584 0.523 0.49 0.523 55 
 
 
 
Table 13 
Cont.  
FS7 AC 88.9444% 86.5084% 87.7577% 82.6359% 86.1337% 88.8819% 87.4453% 88.6321% 87.5703% 
  PR 0.737 0.657 0.669 0.435 0.574 0.698 0.64 0.838 0.667 
  RC 0.45 0.277 0.422 0.39 0.422 0.502 0.442 0.333 0.402 
  FM 0.559 0.39 0.517 0.411 0.486 0.584 0.523 0.477 0.501 
FS8 AC 88.8819% 86.446% 87.6952% 82.6983% 86.1337% 88.6946% 87.4453% 88.5696% 87.5703% 
  PR 0.735 0.7 0.667 0.437 0.574 0.687 0.64 0.83 0.667 
  RC 0.446 0.225 0.418 0.39 0.422 0.502 0.442 0.333 0.402 
  FM 0.555 0.34 0.514 0.412 0.486 0.58 0.523 0.476 0.501 
FS9 AC 88.9444% 86.5084% 87.7577% 82.6359% 86.1337% 88.8819% 87.4453% 88.6321% 87.5703% 
  PR 0.737 0.657 0.669 0.435 0.574 0.698 0.64 0.838 0.667 
  RC 0.45 0.277 0.422 0.39 0.422 0.502 0.442 0.333 0.402 
  FM 0.559 0.39 0.517 0.411 0.486 0.584 0.523 0.477 0.501 
FS10 AC 86.9457% 86.0712% 86.5084% 86.0712% 86.1961% 87.258% 86.8832% 86.321% 86.9457% 
  PR 0.778 0.724 0.732 0.623 0.769 0.836 0.76 0.826 0.763 
  RC 0.225 0.169 0.209 0.265 0.161 0.225 0.229 0.153 0.233 
  FM 0.349 0.274 0.325 0.372 0.266 0.354 0.352 0.258 0.357 
FS11 AC 86.9457% 86.0712% 86.5084% 86.0712% 86.1961% 87.258% 86.8832% 86.321% 86.9457% 
  PR 0.778 0.724 0.732 0.623 0.769 0.836 0.76 0.826 0.763 
  RC 0.225 0.169 0.209 0.265 0.161 0.225 0.229 0.153 0.233 
  FM 0.349 0.274 0.325 0.372 0.266 0.354 0.352 0.258 0.357 
FS12 AC 87.6327% 86.3835% 87.3204% 86.0712% 86.321% 87.5703% 87.3204% 86.6958% 87.5703% 
  PR 0.758 0.763 0.788 0.616 0.768 0.731 0.74 0.821 0.75 
  RC 0.301 0.181 0.253 0.277 0.173 0.317 0.285 0.185 0.301 
  FM 0.431 0.292 0.383 0.382 0.282 0.443 0.412 0.302 0.43 
FS13 AC 86.321% 86.0712% 86.5084% 86.5084% 86.1337% 86.5084% 86.5084% 86.321% 86.321% 
  PR 0.778 0.741 0.824 0.824 0.737 0.824 0.824 0.969 0.778 
  RC 0.169 0.161 0.169 0.169 0.169 0.169 0.169 0.124 0.169 
  FM 0.277 0.264 0.28 0.28 0.275 0.28 0.28 0.221 0.277 56 
 
 
 
Table 13 
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FS14 AC 88.4447% 86.5084% 88.1949% 82.5734% 84.6346% 89.1318% 87.945% 88.757% 89.0693% 
  PR 0.703 0.677 0.679 0.426 0.507 0.714 0.657 0.879 0.734 
  RC 0.446 0.253 0.458 0.345 0.45 0.502 0.47 0.321 0.466 
  FM 0.545 0.368 0.547 0.381 0.477 0.59 0.548 0.471 0.57 
FS15 AC 89.6315% 85.0718% 88.6946% 83.3854% 86.0712% 88.2573% 87.0706% 88.757% 89.0069% 
  PR 0.771 0.586 0.736 0.455 0.676 0.669 0.714 0.863 0.735 
  RC 0.474 0.137 0.426 0.349 0.201 0.486 0.281 0.329 0.458 
  FM 0.587 0.221 0.539 0.395 0.31 0.563 0.403 0.477 0.564 
FS16 AC 86.321% 86.0712% 86.5084% 86.5084% 86.1337% 86.5084% 86.5084% 86.321% 86.321% 
  PR 0.778 0.741 0.824 0.824 0.737 0.824 0.824 0.969 0.778 
  RC 0.169 0.161 0.169 0.169 0.169 0.169 0.169 0.124 0.169 
  FM 0.277 0.264 0.28 0.28 0.275 0.28 0.28 0.221 0.277 
FS17 AC 86.321% 86.0712% 86.5084% 86.5084% 86.1337% 86.5084% 86.5084% 86.321% 86.321% 
  PR 0.778 0.741 0.824 0.824 0.737 0.824 0.824 0.969 0.778 
  RC 0.169 0.161 0.169 0.169 0.169 0.169 0.169 0.124 0.169 
  FM 0.277 0.264 0.28 0.28 0.275 0.28 0.28 0.221 0.277 
FS18 AC 87.5078% 86.6334% 87.4453% 86.0712% 86.321% 87.3204% 87.133% 86.6334% 87.3204% 
  PR 0.753 0.716 0.786 0.616 0.768 0.721 0.736 0.807 0.725 
  RC 0.293 0.233 0.265 0.277 0.173 0.301 0.269 0.185 0.297 
  FM 0.422 0.352 0.396 0.382 0.282 0.425 0.394 0.301 0.422 
FS19 AC 86.321% 86.0712% 86.5084% 86.5084% 86.1337% 86.5084% 86.5084% 86.321% 86.321% 
  PR 0.778 0.741 0.824 0.824 0.737 0.824 0.824 0.969 0.778 
  RC 0.169 0.161 0.169 0.169 0.169 0.169 0.169 0.124 0.169 
  FM 0.277 0.264 0.28 0.28 0.275 0.28 0.28 0.221 0.277 
FS20 AC 88.4447% 86.5084% 88.1949% 82.5734% 84.6346% 89.1318% 87.945% 88.757% 89.0693% 
  PR 0.703 0.677 0.679 0.426 0.507 0.714 0.657 0.879 0.734 
  RC 0.446 0.253 0.458 0.345 0.45 0.502 0.47 0.321 0.466 
  FM 0.545 0.368 0.547 0.381 0.477 0.59 0.548 0.471 0.57 
57 
58 
 
 
Table 13 exhibits the results of the classification process on the clinical dataset. We 
calculated the accuracy (AC), precision (PR), recall (RC) and F-measure (FM). FS15 A1 
(89.6315%) ranked highest in accuracy, FS13 A8, FS16 A8, FS17 A8 and FS19 A8 (0.969) in 
precision FS6 A6 (0.51) for recall and FS14 A6 and FS20 A6 for F-Measure (0.59).  
 The clinical time elapsed table featured in Table 14 shows that based on the sum of the 
time elapsed for feature selection and classification, FS11 and FS16 (0:00:04) had the best 
performance and FS15 (0:07:37) had the poorest performance. 
Table 14 
Clinical Time Elapsed 
Features Classifiers (Time Elapsed) 
Name Time A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 0:00:00 0:00:01 0:00:00 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:03 0:00:02 
FS2 0:00:00 0:00:00 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:02 0:00:02 
FS3 0:00:00 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:02 0:00:03 0:00:02 
FS4 0:00:01 0:00:01 0:00:00 0:00:00 0:00:00 0:00:00 0:00:02 0:00:01 0:00:01 0:00:01 
FS5 0:00:00 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:02 0:00:01 0:00:04 0:00:03 
FS6 0:00:00 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:02 0:00:01 0:00:05 0:00:03 
FS7 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:02 0:00:01 0:00:04 0:00:03 
FS8 0:00:00 0:00:01 0:00:00 0:00:01 0:00:01 0:00:01 0:00:02 0:00:02 0:00:04 0:00:03 
FS9 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:00 0:00:01 0:00:02 0:00:04 0:00:03 
FS10 0:00:00 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:01 
FS11 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:01 
FS12 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:00 0:00:02 0:00:01 0:00:02 0:00:02 
FS13 0:00:05 0:00:01 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 
FS14 0:02:30 0:00:01 0:00:00 0:00:00 0:00:00 0:00:00 0:00:02 0:00:02 0:00:04 0:00:03 
FS15 0:07:19 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:03 0:00:03 0:00:06 0:00:04 
FS16 0:00:02 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:00 
FS17 0:00:05 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:00 0:00:00 
FS18 0:00:06 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:01 
FS19 0:00:02 0:00:00 0:00:00 0:00:01 0:00:00 0:00:00 0:00:01 0:00:00 0:00:01 0:00:00 
FS20 0:01:34 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:02 0:00:01 0:00:04 0:00:03 
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 When considering runtime, reduction in features and recall in Figure 8 below, we have 
determined that FS20 A6 is the better algorithm to use for this dataset. 
 
Figure 8. Top Three Clinical. 
5.4 Medical Dataset   
Table 15 displays the results of the feature selection process on the medical dataset. 
Based solely on feature reduction, FS20 was the top ranking performer by reducing the features 
down to a feature set of 7. FS6 was the lowest ranking performer by only reducing the features 
down to a feature set of 203. 
Table 15 
Medical Feature Set 
Clinical  Feature Set 
Set Attribute  
Evaluator 
Search  
Method 
Classifier # of 
Feat. 
Selected Feature List 
FS1 Cfs Subset 
Eval 
BestFirst  18 49, 104, 105, 112, 123, 129, 245, 
248, 256, 262, 282, 285, 320, 327, 
338, 355, 357, 404 
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FS2 Cfs Subset 
Eval 
Genetic 
Search 
 109 40, 42, 49, 57, 63, 71, 75, 91, 104, 
105, 106, 107, 112, 120, 122, 126, 
127, 129, 131, 137, 139, 140, 144, 
149, 156, 157, 159, 163, 173, 175, 
177, 178, 183, 186, 192, 193, 199, 
201, 209, 219, 222, 226, 228, 231, 
233, 235, 237, 245, 248, 252, 254, 
255, 256, 259, 260, 262, 263, 268, 
269, 274, 275, 276, 282, 283, 289, 
291, 293, 297, 299, 300, 306, 307, 
308, 310, 314, 317, 319, 320, 321, 
323, 327, 331, 332, 333, 334, 336, 
337, 338, 340, 352, 355, 356, 357, 
360, 362, 363, 375, 376, 381, 387, 
389, 390, 392, 397, 399, 401, 404, 
409, 410 
FS3 Cfs 
SubsetEval 
RankSearch  20 49, 63, 91, 104, 105, 112, 123, 129, 
245, 248, 256, 262, 285, 320, 327, 
338, 355, 357, 359, 404 
FS4 Classifier 
SubsetEval 
Genetic 
Search 
OneR 106 40, 41, 48, 49, 52, 54, 56, 57, 61, 
63, 67, 70, 71, 75, 88, 89, 93, 95, 
106, 107, 108, 109, 111, 113, 114, 
115, 126, 127, 129, 131, 134, 137, 
141, 148, 151, 152, 156, 157, 171, 
172, 173, 183, 190, 193, 194, 204, 
207, 208, 211, 212, 215, 216, 221, 
224, 227, 229, 232, 239, 241, 250, 
251, 252, 253, 255, 259, 263, 264, 
265, 268, 269, 276, 284, 285, 290, 
294, 296, 298, 299, 300, 308, 309, 
312, 337, 341, 342, 344, 346, 349, 
350, 359, 363, 366, 371, 376, 379, 
380, 386, 390, 391, 392, 395, 399, 
403, 404, 406, 408 
FS5 Consistency 
SubsetEval 
BestFirst  28 49, 64, 88, 91, 104, 105, 122, 123, 
129, 139, 145, 157, 159, 218, 230, 
245, 250, 262, 282, 285, 311, 320, 
327, 338, 339, 357, 399, 404 
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FS6 Consistency 
SubsetEval 
Genetic 
Search 
 203 39, 43, 47, 48, 49, 52, 53, 56, 57, 58, 61, 64, 
66, 68, 70, 74, 76, 80, 81, 83, 85, 87, 88, 90, 
91, 95, 97, 98, 100 ,101, 104, 105, 110, 111, 
115, 116, 117, 118, 120, 121, 123, 127, 128, 
132, 133, 135, 137, 138, 139, 140, 141, 146, 
147, 148, 149, 150, 152, 153, 154, 155, 157, 
158, 159, 160, 161, 162, 163, 167, 168, 170, 
171, 172, 173, 174, 175, 176, 178, 180, 183, 
184, 185, 186, 187, 188, 190, 194, 197, 198, 
202, 203, 205, 208, 209, 210, 211, 212, 217, 
218, 219, 220, 222, 223, 225, 226, 228, 234, 
235, 237, 238, 239, 240, 241, 242, 243, 244, 
245, 248, 249, 250, 252, 253, 254, 255, 258, 
259, 261, 262, 267, 269, 270, 272, 273, 274, 
275, 277, 278, 279, 281, 282, 283, 285, 287, 
288, 289, 291, 293, 294, 296, 297, 303, 307, 
310 ,311, 312, 314, 315, 317, 319, 320, 322, 
324, 326 ,327, 329, 330, 331, 334, 336, 337, 
338, 339, 343, 344, 347, 350, 351, 353, 354, 
356, 357, 364, 366, 368, 370, 371, 373, 374, 
375, 379, 385, 387, 393, 394, 395, 396, 397, 
398, 399, 401, 402, 404, 405, 406 
FS7 Consistency 
SubsetEval 
Linear 
Forward 
Selection 
 23 49, 91, 104, 105, 112, 120, 122, 129, 139, 
157, 256, 259, 262, 282, 285, 320, 325, 327, 
338, 355, 357, 404, 409 
FS8 Consistency 
SubsetEval 
Rank 
Search 
 78 40, 43, 49, 53, 63, 64, 87, 88, 91, 104, 105, 
112, 120, 122, 123, 124, 126, 129, 135, 139, 
145, 148, 157, 159, 162, 163, 164, 171, 172, 
175, 191, 207, 209, 211, 218, 222, 226, 229, 
230, 245, 246, 247, 248, 249, 250, 251, 254, 
256, 259, 262, 275, 279, 282, 285, 296 297, 
298, 311, 318, 320, 321, 322, 324, 325, 327, 
334, 337, 338, 339, 355, 357, 359, 375, 394, 
399, 400, 404, 409 
FS9 Consistency 
SubsetEval 
Subset 
Size 
Forward 
Selection 
 20 91, 104, 105, 112, 120, 129, 139, 157, 256, 
259, 262, 282, 285, 320, 325, 327, 338, 355, 
357, 404 
FS10 Filtered 
SubsetEval 
BestFirst  14 49, 104, 105, 112, 129, 256, 262, 282, 285, 
320, 327, 338, 357, 404 
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FS11 Filtered 
SubsetEval 
Genetic 
Search 
 109 40, 42, 49, 57, 63, 71, 75, 91, 104, 105, 106, 
107, 112, 120, 122, 126, 127, 129, 131, 137, 
139, 140, 144, 149, 156, 157, 159, 163, 173, 
175, 177, 178, 183, 186, 192, 193, 199, 201, 
209, 219, 222, 226, 228, 231, 233, 235, 237, 
245, 248, 252, 254, 255, 256, 259, 260, 262, 
263, 268, 269, 274, 275, 276, 282, 283, 289, 
291, 293, 297, 299, 300, 306, 307, 308, 310, 
314, 317, 319, 320, 321, 323, 327, 331, 332, 
333, 334, 336, 337, 338, 340, 352, 355, 356, 
357, 360, 362 363, 375, 376, 381, 387, 389, 
390, 392, 397, 399, 401, 404, 409, 410 
FS12 Filtered 
SubsetEval 
Rank 
Search 
 13 63, 91, 104, 112, 129, 256, 285, 320, 327, 
338, 357, 359, 404 
FS13 Wrapper 
SubsetEval 
BestFirst Naïve 
Bayes 
16 41, 56, 63, 104, 105, 123, 145, 153, 222, 
248, 249, 256, 285, 320, 338, 404 
FS14 Wrapper 
SubsetEval 
BestFirst Bagging 14 43, 49, 50, 54, 61, 256, 261, 285, 293, 298, 
320, 327, 338, 404 
FS15 Wrapper 
SubsetEval 
Genetic 
Search 
Bagging 192 39, 40, 43, 47, 50, 53, 55, 57, 60, 62, 63, 64, 
69, 70, 72, 73, 75, 77, 78, 80, 81, 82, 83, 85, 
89, 90, 91, 92, 100, 102, 103, 104, 108, 109, 
110, 112, 113, 115, 118, 119, 121, 122, 126, 
127, 129, 130, 131, 133, 135, 136, 140, 142, 
148, 152, 153, 155, 156, 157, 158, 160, 163, 
165, 168, 169, 172, 173, 174, 175, 176, 177, 
178, 181, 185, 188, 189, 192, 193, 196, 198, 
199, 201, 202, 203, 204, 205, 206, 207, 208, 
209, 210, 212, 216, 218, 221, 223, 226, 227, 
229, 231, 234, 235, 236, 237, 240, 242, 244, 
246, 248, 249, 253, 254, 255, 258, 262, 264, 
265, 269, 271, 272, 274, 277, 278, 279, 280, 
281, 282, 284, 285, 286, 287, 288, 289, 292, 
294, 296, 297, 298, 300, 302, 303, 304, 305, 
306, 309, 310, 314, 317, 318, 320, 321, 322, 
323, 325, 326, 327, 328, 335, 336, 338, 342, 
345, 346, 347, 353, 357, 360, 361, 362, 365, 
366, 367, 370, 371, 373, 375, 376, 377, 382, 
383, 386, 387, 388, 390, 392, 393, 395, 397, 
401, 403, 404, 408, 410 
FS16 Wrapper 
SubsetEval 
Greedy 
Stepwise 
Naïve 
Bayes 
16 41, 56, 63, 104, 105, 123, 145, 153, 222, 
248, 249, 256, 285, 320, 338, 404 
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FS17 Wrapper 
SubsetEval 
Linear 
Forward 
Selection 
Naïve 
Bayes 
14 64, 104, 105, 112, 129, 157, 256, 285, 320, 
327, 338, 357, 404, 409 
FS18 Wrapper 
SubsetEval 
RankSear
ch 
Naïve 
Bayes 
11 91, 104, 112, 129, 256, 285, 320, 327, 338, 
359, 404 
FS19 Wrapper 
SubsetEval 
Subset 
SizeForw
ardSelect
ion 
Naïve 
Bayes 
14 64, 104, 105, 112, 129, 157, 256, 285, 320, 
327, 338, 357, 404, 409 
FS20 Wrapper 
SubsetEval 
Subset 
SizeForw
ardSelect
ion 
Bagging 7 49, 256, 285, 320, 327, 338, 404 
 
Table 16 exhibits the results of the classification process on the medical dataset. We 
calculated the accuracy (AC), precision (PR), recall (RC) and F-measure (FM). FS14 A1 
(94.7533%) ranked highest in accuracy, FS12 A8 (0.989) in precision FS3 A6 (0.876) for recall 
and FS17 A2 and FS17 A2 for F-Measure (0.861).  
The medical elapsed table featured in Table 17 shows that based on the sum of the time 
elapsed for feature selection and classification, FS10 (0:00:20) had the best performance and 
FS15 (2:59:48) had the poorest performance. 
 
 
 
 
Table 16 
Medical: Precision, Recall and F-Measure Rates 
Features Classifiers 
Name Metric A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 AC 94.5659% 95.1905% 93.6914% 95.3154% 90.2561% 95.3779% 94.3785% 90.5059% 95.253% 
  PR 0.84 0.877 0.811 0.878 0.872 0.846 0.912 0.98 0.847 
  RC 0.803 0.803 0.775 0.811 0.438 0.859 0.707 0.398 0.847 
  FM 0.821 0.839 0.793 0.843 0.583 0.853 0.796 0.566 0.847 
FS2 AC 94.6284% 92.817% 93.6914% 93.3791% 89.7564% 94.6284% 93.5041% ERROR 94.8782% 
  PR 0.856 0.775 0.846 0.783 0.851 0.841 0.892  0.849 
  RC 0.787 0.759 0.727 0.795 0.414 0.807 0.663  0.815 
  FM 0.82 0.767 0.782 0.789 0.557 0.824 0.76  0.832 
FS3 AC 94.5659% 95.128% 93.3167% 95.3779% 90.381% 95.253% 94.441% 90.9432% 95.0656% 
  PR 0.84 0.901 0.809 0.882 0.874 0.829 0.921 0.981 0.84 
  RC 0.803 0.771 0.747 0.811 0.446 0.876 0.703 0.426 0.843 
  FM 0.821 0.831 0.777 0.845 0.59 0.852 0.797 0.594 0.842 
FS4 AC 92.0675% 88.9444% 91.0681% 90.0687% 88.6321% 91.4428% 90.9432% ERROR 92.4422% 
  PR 0.777 0.698 0.765 0.718 0.813 0.728 0.806  0.776 
  RC 0.687 0.51 0.614 0.594 0.349 0.719 0.55  0.723 
  FM 0.729 0.589 0.682 0.651 0.489 0.723 0.654  0.748 
FS5 AC 94.5034% 94.5659% 94.2536% 94.5659% 90.2561% 95.6277% 94.0037% 90.0687% 94.8782% 
  PR 0.845 0.852 0.843 0.84 0.872 0.857 0.87 0.925 0.849 
  RC 0.791 0.787 0.775 0.803 0.438 0.863 0.723 0.394 0.815 
  FM 0.817 0.818 0.808 0.821 0.583 0.86 0.789 0.552 0.832 
FS6 AC 94.5659% 88.5072% 93.7539% 92.5047% 90.2561% 95.4403% 94.0037% ERROR 94.3785% 
  PR 0.846 0.637 0.828 0.738 0.872 0.879 0.856  0.809 
  RC 0.795 0.606 0.755 0.803 0.438 0.819 0.739  0.835 
  FM 0.82 0.621 0.79 0.769 0.583 0.848 0.793  0.822 64 
 
 
 
Table 16 
Cont.  
FS7 AC 94.8157% 94.5034% 94.0662% 94.7533% 89.2567% 95.128% 94.1287% 89.7564% 95.5028% 
  PR 0.855 0.858 0.85 0.842 0.789 0.846 0.886 0.967 0.864 
  RC 0.803 0.775 0.751 0.815 0.422 0.839 0.715 0.353 0.843 
  FM 0.828 0.814 0.797 0.829 0.55 0.843 0.791 0.518 0.854 
FS8 AC 94.8782% 92.3798% 94.441% 93.1918% 90.2561% 95.253% 94.1287% 89.1943% 94.6284% 
  PR 0.855 0.766 0.854 0.759 0.872 0.842 0.871 0.888 0.825 
  RC 0.807 0.735 0.775 0.823 0.438 0.855 0.731 0.349 0.831 
  FM 0.831 0.75 0.813 0.79 0.583 0.849 0.795 0.501 0.828 
FS9 AC 95.0656% 94.3161% 94.8157% 94.8782% 89.3816% 94.8157% 94.1911% 89.8813% 95.3779% 
  PR 0.863 0.819 0.864 0.861 0.793 0.835 0.868 0.958 0.866 
  RC 0.811 0.815 0.791 0.799 0.43 0.831 0.739 0.365 0.831 
  FM 0.836 0.817 0.826 0.829 0.557 0.833 0.798 0.529 0.848 
FS10 AC 95.0031% 94.7533% 94.1911% 95.0656% 89.2567% 95.1905% 94.3785% 89.8813% 95.3779% 
  PR 0.854 0.834 0.831 0.873 0.789 0.85 0.896 0.968 0.866 
  RC 0.819 0.827 0.787 0.799 0.422 0.839 0.723 0.361 0.831 
  FM 0.836 0.831 0.808 0.834 0.55 0.844 0.8 0.526 0.848 
FS11 AC 94.6284% 92.817% 93.6914% 93.3791% 89.7564% 94.6284% 93.5041% ERROR 94.8782% 
  PR 0.856 0.775 0.846 0.783 0.851 0.841 0.892  0.849 
  RC 0.787 0.759 0.727 0.795 0.414 0.807 0.663  0.815 
  FM 0.82 0.767 0.782 0.789 0.557 0.824 0.76  0.832 
FS12 AC 95.0031% 95.128% 94.3161% 95.0031% 89.6939% 95.0656% 94.5034% 90.0687% 95.3779% 
  PR 0.897 0.917 0.88 0.916 0.796 0.897 0.935 0.989 0.915 
  RC 0.767 0.755 0.735 0.747 0.454 0.771 0.695 0.365 0.775 
  FM 0.827 0.828 0.801 0.823 0.578 0.829 0.797 0.534 0.839 
FS13 AC 94.5659% 95.0031% 93.7539% 95.5653% 89.2567% 94.6908% 93.8164% 89.0693% 95.253% 
  PR 0.832 0.879 0.82 0.894 0.881 0.839 0.899 0.987 0.868 
  RC 0.815 0.787 0.767 0.811 0.357 0.815 0.679 0.301 0.819 
  FM 0.824 0.831 0.793 0.851 0.509 0.827 0.773 0.462 0.843 65 
 
 
 
Table 16 
Cont.  
FS14 AC 94.7533% 93.2542% 93.3791% 92.817% 89.1318% 94.8157% 93.3791% 88.1949% 94.6908% 
  PR 0.857 0.831 0.839 0.807 0.879 0.855 0.891 0.955 0.866 
  RC 0.795 0.711 0.711 0.707 0.349 0.803 0.655 0.253 0.779 
  FM 0.825 0.766 0.77 0.754 0.5 0.828 0.755 0.4 0.82 
FS15 AC 94.8782% 85.4466% 94.6908% 93.0668% 89.3816% 94.9407% 94.0037% ERROR 94.9407% 
  PR 0.841 0.608 0.833 0.778 0.788 0.844 0.901  0.831 
  RC 0.827 0.181 0.823 0.775 0.434 0.827 0.691  0.847 
  FM 0.834 0.279 0.828 0.777 0.56 0.836 0.782  0.839 
FS16 AC 94.5659% 95.0031% 93.7539% 95.5653% 89.2567% 94.6908% 93.8164% 89.0693% 95.2530% 
  PR 0.832 0.879 0.82 0.894 0.881 0.839 0.899 0.987 0.868 
  RC 0.815 0.787 0.767 0.811 0.357 0.815 0.679 0.301 0.819 
  FM 0.824 0.831 0.793 0.851 0.509 0.827 0.773 0.462 0.843 
FS17 AC 94.8782% 95.7527% 94.1911% 95.5028% 89.3816% 95.0031% 94.3161% 90.1936% 95.3779% 
  PR 0.861 0.876 0.855 0.9 0.793 0.848 0.873 0.979 0.876 
  RC 0.799 0.847 0.755 0.799 0.43 0.827 0.743 0.378 0.819 
  FM 0.829 0.861 0.802 0.847 0.557 0.837 0.803 0.545 0.846 
FS18 AC 94.441% 95.0656% 93.2542% 95.0031% 89.569% 95.3154% 94.5659% 89.3192% 95.253% 
  PR 0.857 0.925 0.89 0.933 0.887 0.91 0.955 0.988 0.918 
  RC 0.771 0.743 0.647 0.731 0.378 0.775 0.683 0.317 0.763 
  FM 0.812 0.824 0.749 0.82 0.53 0.837 0.796 0.48 0.833 
FS19 AC 94.8782% 95.7527% 94.1911% 95.5028% 89.3816% 95.0031% 94.3161% 90.1936% 95.3779% 
  PR 0.861 0.876 0.855 0.9 0.793 0.848 0.873 0.979 0.876 
  RC 0.799 0.847 0.755 0.799 0.43 0.827 0.743 0.378 0.819 
  FM 0.829 0.861 0.802 0.847 0.557 0.837 0.803 0.545 0.846 
FS20 AC 94.8157% 94.3785% 93.6914% 94.1287% 89.1318% 94.6284% 93.4416% 88.2573% 94.7533% 
  PR 0.861 0.866 0.856 0.886 0.879 0.853 0.891 0.969 0.863 
  RC 0.795 0.755 0.715 0.715 0.349 0.791 0.659 0.253 0.787 
  FM 0.827 0.807 0.779 0.791 0.5 0.821 0.758 0.401 0.824 66 
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Table 17 
Medical Time Elapsed 
Features Classifiers (Time Elapsed) 
Name Time A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 0:00:02 0:00:01 0:00:00 0:00:01 0:00:00 0:00:02 0:00:04 0:00:03 0:00:10 0:00:02 
FS2 0:00:08 0:00:07 0:00:03 0:00:07 0:00:01 0:00:08 0:00:09 0:00:16 0:00:52 0:00:16 
FS3 0:00:08 0:00:25 0:00:01 0:00:02 0:00:00 0:00:04 0:00:15 0:00:05 0:00:32 0:00:03 
FS4 0:00:20 0:00:08 0:00:02 0:00:07 0:00:01 0:00:08 0:00:19 0:00:14 0:00:59 0:00:21 
FS5 0:00:14 0:00:02 0:00:01 0:00:02 0:00:00 0:00:02 0:00:04 0:00:04 0:00:16 0:00:03 
FS6 0:00:02 0:00:14 0:00:04 0:00:15 0:00:02 0:00:14 0:00:11 0:00:27 0:01:39 0:00:37 
FS7 0:00:02 0:00:11 0:00:01 0:00:02 0:00:00 0:00:01 0:00:08 0:00:03 0:00:09 0:00:03 
FS8 0:00:03 0:00:05 0:00:02 0:00:05 0:00:01 0:00:06 0:00:08 0:00:11 0:00:32 0:00:09 
FS9 0:00:02 0:00:02 0:00:01 0:00:01 0:00:00 0:00:02 0:00:07 0:00:03 0:00:09 0:00:03 
FS10 0:00:02 0:00:01 0:00:01 0:00:01 0:00:00 0:00:02 0:00:04 0:00:02 0:00:05 0:00:02 
FS11 0:00:08 0:00:06 0:00:02 0:00:08 0:00:01 0:00:07 0:00:08 0:00:15 0:00:50 0:00:15 
FS12 0:00:07 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:04 0:00:01 0:00:05 0:00:02 
FS13 0:13:53 0:00:02 0:00:01 0:00:01 0:00:00 0:00:01 0:00:05 0:00:02 0:00:07 0:00:02 
FS14 1:19:37 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:04 0:00:02 0:00:05 0:00:02 
FS15 2:56:07 0:00:17 0:00:04 0:00:14 0:00:02 0:00:13 0:00:24 0:00:26 0:01:18 0:00:43 
FS16 0:09:58 0:00:02 0:00:01 0:00:01 0:00:00 0:00:01 0:00:05 0:00:02 0:00:07 0:00:02 
FS17 0:01:32 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:04 0:00:02 0:00:06 0:00:01 
FS18 0:12:51 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:04 0:00:01 0:00:04 0:00:01 
FS19 0:01:07 0:00:01 0:00:00 0:00:01 0:00:00 0:00:01 0:00:05 0:00:02 0:00:06 0:00:01 
FS20 0:02:13 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:02 0:00:01 0:00:03 0:00:01 
 
When considering runtime, reduction in features and recall in Figure 9 below, we have 
determined that FS19 A2 is the better algorithm to use for this dataset. 
 
Figure 9. Top Three Medical. 
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5.5 Clean Full Dataset   
Table 18 displays the results of the feature selection process on the clean full dataset. 
Based solely on feature reduction, FS20 was the top ranking performer by reducing the features 
down to a feature set of 4. FS15 was the lowest ranking performer by only reducing the features 
down to a feature set of 214.  
Table 18 
Clean Full Feature Set 
Clinical  Feature Set 
Set Attribute  
Evaluator 
Search  
Method 
Classifier # of 
Feat. 
Selected Feature List 
FS1 Cfs Subset 
Eval 
BestFirs
t 
 13 34,105,248,285,320,322,338,404,411,41
4,416,417,418 
FS2 Cfs Subset 
Eval 
Genetic 
Search 
 134 3,13,19,27,29,31,34,35,54,64,67,73,75,8
2,86,87,88,96,97,104,112,122,128,129,1
31,145,147,148,155,164,167,169,173,17
5,176,181,187,188,194,196,209,218,222
,228,229,232,236,239,243,244,248,251,
252,256,258,260,261,263,266,268,271,2
74,276,280,282,287,289,291,299,301,30
2,305,306,307,308,310,311,314,316,317
,318,320,324,327,328,332,334,335,337,
338,339,340,348,350,352,353,354,356,3
57,359,360,361,362,363,364,366,370,37
5,376,379,381,382,383,384,385,387,390
,392,394,395,396,399,403,404,405,407,
410,411,413,414,415,416,417,418 
FS3 Cfs 
SubsetEval 
Rank 
Search 
 16 34,91,104,105,248,256,320,327,338,394
,404,411,414,416,417,418 
FS4 Classifier 
SubsetEval 
Genetic 
Search 
OneR 103 2,3,6,10,14,19,30,40,41,43,45,47,53,58,
62,68,69,70,74,78,89,90,91,92,93,97,10
0,101,104,108,110,111,127,129,130,131
,137,140,165,171,172,178,181,184,186,
192,199,205,206,214,216,217,220,222,2
27,228,232,235,243,244,246,250,251,25
8,260,262,263,266,275,285,286,290,291
,298,301,302,304,306,313,315,323,336,
338,343,346,348,349,351,352,354,359,3
61,363,373,378,381,382,397,400,409,41
1,415,418 
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Table 18 
Cont. 
FS5 Consistency 
SubsetEval 
BestFirst  9 2,28,33,285,411,412,414,416,418 
FS6 Consistency 
SubsetEval 
Genetic 
Search 
 170 1,2,4,5,9,12,13,17,19,22,23,25,27,28,30,
31,32,33,34,35,38,40,41,42,43,45,46,47,
50,52,53,54,57,59,60,61,62,63,65,66,67,
69,70,71,77,79,81,82,84,91,94,99,102,1
04,106,109,111,115,117,118,119,123,12
9,131,132,142,144,145,151,153,154,155
,159,161,165,171,178,181,184,186,192,
193,194,195,197,199,201,203,205,206,2
10,213,214,215,217,220,222,223,229,23
2,235,243,244,245,251,258,259,260,262
,263,267,272,274,275,276,277,281,285,
286,289,290,295,298,301,302,303,304,3
05,313,314,325,328,331,333,336,338,34
1,343,344,345,346,348,349,350,352,361
,363,366,371,372,383,386,389,392,393,
394,395,396,403,404,405,409,410,411,4
12,413,414,415,416,417 
FS7 Consistency 
SubsetEval 
Linear 
Forward 
Selection 
 12 2,34,49,105,285,320,338,357,411,414,4
16,418 
FS8 Consistency 
SubsetEval 
Rank 
Search 
 96 2,7,16,20,23,25,29,30,33,34,43,49,53,54
,63,64,69,87,88,91,104,105,112,120,122
,123,124,126,129,131,135,139,141,145,
148,157,159,162,163,164,171,172,191,2
07,209,211,218,226,229,230,245,246,24
8,249,250,251,254,256,259,262,275,279
,282,285,296,297,298,311,318,320,321,
322,324,325,327,334,335,337,338,339,3
55,357,359,375,384,394,400,404,409,41
1,412,413,414,416,417,418 
FS9 Consistency 
SubsetEval 
SubsetSize 
Forward 
Selection 
 10 2,34,49,105,285,357,411,414,416,418 
FS10 Filtered 
SubsetEval 
BestFirst  10 105,285,320,338,404,411,414,416,417,4
18 
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Table 18 
Cont. 
FS11 Filtered 
SubsetEval 
Genetic 
Search 
 134 3,13,19,27,29,31,34,35,54,64,67,73,75,82,
86,87,88,96,97,104,112,122,128,129,131,
145,147,148,155,164,167,169,173,175,17
6,181,187,188,194,196,209,218,222,228,2
29,232,236,239,243,244,248,251,252,256,
258,260,261,263,266,268,271,274,276,28
0,282,287,289,291,299,301,302,305,306,3
07,308,310,311,314,316,317,318,320,324,
327,328,332,334,335,337,338,339,340,34
8,350,352,353,354,356,357,359,360,361,3
62,363,364,366,370,375,376,379,381,382,
383,384,385,387,390,392,394,395,396,39
9,403,404,405,407,410,411,413,414,415,4
16,417,418 
FS12 Filtered 
SubsetEval 
Rank 
Search 
 10 1,104,256,320,327,338,404,411,414,417 
FS13 Wrapper 
SubsetEval 
BestFirst Naïve 
Bayes 
11 1,14,21,43,75,130,145,185,213,285,411 
FS14 Wrapper 
SubsetEval 
BestFirst Bagging 15 2,5,20,65,207,256,269,305,320,334,348,3
73,399,402,411 
FS15 Wrapper 
SubsetEval 
Genetic 
Search 
Bagging 214 1,2,7,9,10,14,15,17,19,21,23,27,28,31,32,
33,34,35,36,39,41,43,44,47,48,49,54,60,6
1,62,63,64,66,67,68,70,71,74,75,79,80,85,
92,94,96,99,100,102,103,107,112,113,114
,119,121,123,125,126,127,128,133,134,13
6,139,142,143,145,149,150,157,158,160,1
61,163,165,169,171,172,178,180,181,183,
184,185,186,188,189,190,193,194,196,20
0,201,204,206,210,212,213,215,216,217,2
18,219,220,222,223,224,225,227,228,229,
230,231,232,233,234,235,237,239,240,24
3,244,245,246,247,248,249,251,254,255,2
59,263,265,266,267,271,273,274,276,278,
279,281,283,284,286,291,292,293,294,29
5,296,299,301,302,304,306,310,313,314,3
17,318,319,320,321,322,323,326,327,330,
331,332,333,334,336,338,339,341,344,35
2,353,354,355,356,357,358,359,366,368,3
69,370,371,372,377,379,380,381,382,383,
386,387,388,389,392,393,395,396,398,40
4,405,407,409,414,416,417 
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Table 18 
Cont. 
FS16 Wrapper 
SubsetEval 
Greedy 
Stepwise 
Naïve 
Bayes 
7 14,21,130,145,185,285,411 
FS17 Wrapper 
SubsetEval 
Linear 
Forward 
Selection 
Naïve 
Bayes 
9 104,105,124,285,327,337,338,411,417 
FS18 Wrapper 
SubsetEval 
Rank 
Search 
Naïve 
Bayes 
10 91,104,256,320,327,338,404,411,414,417 
FS19 Wrapper 
SubsetEval 
SubsetSize 
Forward 
Selection 
Naïve 
Bayes 
5 104,105,285,411,417 
FS20 Wrapper 
SubsetEval 
SubsetSize 
Forward 
Selection 
Bagging 4 7,104,411,418 
 
Table 19 exhibits the results of the classification process on the clean full dataset. We 
calculated the accuracy (AC), precision (PR), recall (RC) and F-measure (FM). FS8 A6 
(97.5015%) ranked highest in accuracy, FS20 A8 (0.977) in precision, FS5 A1 (0.981) for recall 
and FS8 A6 for F-Measure (0.919). Based solely on AC and FM, FS8 A6 is the top ranking 
performer.  
 The clean full time elapsed table featured in Table 20 shows that based on the sum of the 
time elapsed for feature selection and classification, FS7 (0:00:23) had the best performance and 
FS14 (1:59:59) had the poorest performance.
 
 
 
Table 19 
Clean: Precision, Recall and F-Measure Rates 
Features Classifiers 
Name Metric A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 AC 96.1333% 96.4902% 96.1333% 96.4902% 95.8358% 97.0851% 96.7281% 96.6686% 96.7876% 
  PR 0.887 0.878 0.893 0.87 0.87 0.935 0.916 0.941 0.895 
  RC 0.864 0.902 0.856 0.913 0.864 0.875 0.871 0.841 0.902 
  FM 0.875 0.89 0.874 0.891 0.867 0.904 0.893 0.888 0.898 
FS2 AC 96.7281% 93.0399% 97.0851% 94.5866% 96.4307% 97.1446% 97.0256% ERROR 96.0143% 
  PR 0.91 0.793 0.918 0.817 0.889 0.958 0.918  0.838 
  RC 0.879 0.754 0.894 0.845 0.883 0.856 0.89  0.924 
  FM 0.894 0.773 0.906 0.831 0.886 0.904 0.904  0.879 
FS3 AC 96.0738% 96.1927% 96.0143% 96.6092% 95.8953% 96.4902% 96.7281% 96.0738% 96.7281% 
  PR 0.884 0.888 0.899 0.894 0.871 0.915 0.91 0.93 0.92 
  RC 0.864 0.867 0.841 0.89 0.867 0.856 0.879 0.811 0.867 
  FM 0.874 0.877 0.869 0.892 0.869 0.885 0.894 0.866 0.893 
FS4 AC 96.8471% 92.9209% 96.7876% 94.884% 95.8358% 96.5497% 96.3712% ERROR 96.0143% 
  PR 0.907 0.817 0.907 0.83 0.862 0.926 0.889  0.856 
  RC 0.89 0.708 0.886 0.848 0.875 0.848 0.879  0.898 
  FM 0.899 0.759 0.897 0.839 0.868 0.885 0.884  0.876 
FS5 AC 96.4902% 96.0738% 96.0738% 95.5979% 96.0143% 97.204% 96.3712% 97.0851% 95.7168% 
  PR 0.977 0.899 0.893 0.889 0.872 0.939 0.898 0.928 0.869 
  RC 0.981 0.845 0.852 0.822 0.875 0.879 0.867 0.883 0.856 
  FM 0.979 0.871 0.872 0.854 0.873 0.908 0.882 0.905 0.863 
FS6 AC 96.9661% 85.9607% 96.4307% 95.4194% 95.9548% 96.8471% 96.9066% ERROR 97.1446% 
  PR 0.918 0.566 0.892 0.828 0.868 0.945 0.914  0.903 
  RC 0.886 0.455 0.879 0.894 0.875 0.848 0.886  0.917 
  FM 0.902 0.504 0.885 0.86 0.872 0.894 0.9  0.91 72 
 
 
 
Table 19 
Cont.  
FS7 AC 96.6092% 96.4902% 96.1927% 96.1333% 96.0143% 96.6092% 96.5497% 97.204% 96.7876% 
  PR 0.903 0.881 0.897 0.849 0.877 0.919 0.896 0.943 0.904 
  RC 0.879 0.898 0.856 0.917 0.867 0.86 0.883 0.875 0.89 
  FM 0.891 0.889 0.876 0.882 0.872 0.888 0.889 0.908 0.897 
FS8 AC 96.7281% 94.0512% 96.4307% 93.6347% 95.9548% 97.5015% 96.8471% ERROR 96.6092% 
  PR 0.91 0.801 0.902 0.756 0.868 0.934 0.917  0.9 
  RC 0.879 0.826 0.867 0.879 0.875 0.905 0.879  0.883 
  FM 0.894 0.813 0.884 0.813 0.872 0.919 0.897  0.891 
FS9 AC 96.6092% 95.7763% 95.9548% 95.4789% 96.0143% 96.4902% 96.5497% 97.0851% 96.3117% 
  PR 0.9 0.853 0.883 0.829 0.877 0.912 0.896 0.942 0.898 
  RC 0.883 0.883 0.856 0.898 0.867 0.86 0.883 0.867 0.864 
  FM 0.891 0.868 0.869 0.862 0.872 0.885 0.889 0.903 0.88 
FS10 AC 96.3117% 96.3712% 96.1927% 96.2522% 95.9548% 96.9661% 96.4902% 96.1927% 96.4307% 
  PR 0.898 0.886 0.888 0.879 0.877 0.931 0.908 0.924 0.892 
  RC 0.864 0.883 0.867 0.883 0.864 0.871 0.864 0.826 0.879 
  FM 0.88 0.884 0.877 0.881 0.87 0.9 0.885 0.872 0.885 
FS11 AC 96.7281% 93.0399% 97.0851% 94.5866% 96.4307% 97.1446% 97.0256% ERROR 96.0143% 
  PR 0.91 0.793 0.918 0.817 0.889 0.958 0.918  0.838 
  RC 0.879 0.754 0.894 0.845 0.883 0.856 0.89  0.924 
  FM 0.894 0.773 0.906 0.831 0.886 0.904 0.904  0.879 
FS12 AC 95.8953% 95.8953% 95.7763% 96.1333% 95.8358% 95.4194% 95.9548% 95.122% 96.3117% 
  PR 0.892 0.885 0.918 0.913 0.862 0.87 0.871 0.96 0.935 
  RC 0.841 0.848 0.803 0.833 0.875 0.833 0.871 0.72 0.822 
  FM 0.865 0.867 0.857 0.871 0.868 0.851 0.871 0.823 0.875 
FS13 AC 96.7281% 96.3712% 96.5497% 96.7281% 95.8358% 96.5497% 96.3117% 94.2296% 96.6092% 
  PR 0.897 0.88 0.879 0.886 0.862 0.906 0.888 0.947 0.888 
  RC 0.894 0.89 0.905 0.909 0.875 0.871 0.875 0.67 0.898 
  FM 0.896 0.885 0.892 0.897 0.868 0.888 0.882 0.785 0.893 73 
 
 
 
Table 19 
Cont.  
FS14 AC 96.7281% 94.1701% 96.8471% 94.7055% 95.8358% 97.204% 96.0738% 96.6092% 96.1927% 
  PR 0.91 0.855 0.907 0.86 0.862 0.919 0.875 0.948 0.894 
  RC 0.879 0.758 0.89 0.792 0.875 0.902 0.875 0.83 0.86 
  FM 0.894 0.803 0.899 0.824 0.868 0.91 0.875 0.885 0.876 
FS15 AC 97.204% 91.1362% 96.3117% 94.2891% 95.8358% 96.9661% 96.4902% ERROR 96.1927% 
  PR 0.936 0.719 0.888 0.804 0.898 0.949 0.932  0.855 
  RC 0.883 0.716 0.875 0.841 0.83 0.852 0.837  0.913 
  FM 0.908 0.717 0.882 0.822 0.862 0.898 0.882  0.883 
FS16 AC 96.3117% 96.3712% 96.1333% 96.7281% 95.8358% 95.1814% 96.3117% 93.8727% 96.4902% 
  PR 0.888 0.872 0.859 0.886 0.862 0.851 0.895 0.945 0.896 
  RC 0.875 0.902 0.902 0.909 0.875 0.841 0.867 0.648 0.879 
  FM 0.882 0.886 0.88 0.897 0.868 0.846 0.881 0.769 0.887 
FS17 AC 96.1333% 96.3117% 96.0738% 97.0256% 95.8358% 96.1333% 95.8358% 94.2891% 96.6092% 
  PR 0.9 0.856 0.878 0.925 0.862 0.887 0.865 0.947 0.888 
  RC 0.848 0.92 0.871 0.883 0.875 0.864 0.871 0.674 0.898 
  FM 0.873 0.887 0.875 0.903 0.868 0.875 0.868 0.788 0.893 
FS18 AC 95.8953% 95.8953% 95.7763% 96.1333% 95.8358% 95.4194% 95.9548% 95.122% 96.3117% 
  PR 0.892 0.885 0.918 0.913 0.862 0.87 0.871 0.96 0.935 
  RC 0.841 0.848 0.803 0.833 0.875 0.833 0.871 0.72 0.822 
  FM 0.865 0.867 0.857 0.871 0.868 0.851 0.871 0.823 0.875 
FS19 AC 96.1927% 96.4902% 96.0738% 96.8471% 95.8358% 96.1927% 95.8358% 94.5271% 96.4307% 
  PR 0.903 0.873 0.878 0.901 0.862 0.882 0.865 0.943 0.889 
  RC 0.848 0.909 0.871 0.898 0.875 0.875 0.871 0.693 0.883 
  FM 0.875 0.891 0.875 0.899 0.868 0.878 0.868 0.799 0.886 
FS20 AC 96.4307% 96.0143% 96.7281% 95.6573% 95.8358% 96.6686% 96.2522% 96.3712% 96.6092% 
  PR 0.911 0.896 0.913 0.88 0.862 0.916 0.888 0.977 0.937 
  RC 0.856 0.845 0.875 0.837 0.875 0.867 0.871 0.788 0.841 
  FM 0.883 0.869 0.894 0.858 0.868 0.891 0.88 0.872 0.886 
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Table 20 
Clean Time Elapsed 
Features Classifiers (Time Elapsed) 
Name Time A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 0:00:02 0:00:01 0:00:02 0:00:01 0:00:01 0:00:01 0:00:01 0:00:02 0:00:15 0:00:02 
FS2 0:00:10 0:00:04 0:00:02 0:00:04 0:00:01 0:00:10 0:00:04 0:00:20 0:01:39 0:00:14 
FS3 0:00:09 0:00:01 0:00:01 0:00:00 0:00:00 0:00:02 0:00:02 0:00:03 0:00:16 0:00:02 
FS4 0:00:10 0:00:04 0:00:03 0:00:03 0:00:01 0:00:08 0:00:04 0:00:16 0:01:21 0:00:12 
FS5 0:00:05 0:00:00 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:02 0:00:14 0:00:02 
FS6 0:00:02 0:00:05 0:00:05 0:00:05 0:00:02 0:00:13 0:00:04 0:00:26 0:01:52 0:00:14 
FS7 0:00:01 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:14 0:00:02 
FS8 0:00:04 0:00:04 0:00:03 0:00:03 0:00:02 0:00:07 0:00:04 0:00:14 0:00:59 0:00:10 
FS9 0:00:02 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:02 0:00:01 0:00:14 0:00:01 
FS10 0:00:01 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:14 0:00:23 
FS11 0:00:10 0:00:05 0:00:03 0:00:05 0:00:01 0:00:10 0:00:05 0:00:21 0:01:36 0:00:14 
FS12 0:00:10 0:00:01 0:00:02 0:00:01 0:00:01 0:00:01 0:00:01 0:00:02 0:00:10 0:00:02 
FS13 0:11:11 0:00:00 0:00:01 0:00:01 0:00:00 0:00:01 0:00:02 0:00:02 0:00:09 0:00:03 
FS14 1:59:40 0:00:00 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:02 0:00:10 0:00:03 
FS15 1:19:33 0:00:14 0:00:07 0:00:08 0:00:01 0:00:17 0:00:05 0:00:33 0:02:07 0:00:22 
FS16 0:03:24 0:00:00 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:01 0:00:06 0:00:02 
FS17 0:01:15 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:06 0:00:01 
FS18 0:26:58 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:08 0:00:01 
FS19 0:00:19 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:01 0:00:05 0:00:01 
FS20 0:01:36 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:07 0:00:01 
 
When considering runtime, reduction in features and recall in Figure 10 below, we have 
determined that FS8 A6 is the better algorithm to use for this dataset. 
 
Figure 10. Top Three Clean Full. 
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5.6 Clean Clinical Dataset   
Table 21 displays the results of the feature selection process on the clean clinical dataset. 
Based solely on feature reduction, FS13, FS16 and FS19 were the top ranking performers by 
reducing the features down to a feature set of 2. FS15 was the lowest ranking performer by only 
reducing the features down to a feature set of 16.  
Table 21 
Clean Clinical Feature Set 
Clinical  Feature Set 
Set Attribute  
Evaluator 
Search  
Method 
Classifier # of 
Feat. 
Selected Feature List 
FS1 Cfs Subset 
Eval 
BestFirst  6 20, 21, 25, 29, 33, 34 
FS2 Cfs Subset 
Eval 
Genetic 
Search 
 6 20, 21, 25, 29, 33, 34 
FS3 Cfs 
SubsetEval 
RankSearch  7 20, 21, 23, 25, 29, 33, 34 
FS4 Classifier 
SubsetEval 
Genetic 
Search 
OneR 5 13, 14, 24, 27, 34 
FS5 Consistency 
SubsetEval 
BestFirst  10 20, 21, 23, 25, 28, 29, 30, 33, 34, 38 
FS6 Consistency 
SubsetEval 
Genetic 
Search 
 14 13, 19, 20, 21, 22, 23, 24, 25, 28, 
29, 30, 33, 34, 38 
FS7 Consistency 
SubsetEval 
Linear 
Forward 
Selection 
 10 20, 21, 23, 25, 28, 29, 30, 33, 34, 38 
FS8 Consistency 
SubsetEval 
RankSearch  11 16, 20, 21, 23, 25, 28, 29, 30, 33, 
34, 38 
FS9 Consistency 
SubsetEval 
Subset 
SizeForward
Selection 
 10 20, 21, 23, 25, 28, 29, 30, 33, 34, 38 
FS10 Filtered 
SubsetEval 
BestFirst  3 29, 33, 34 
FS11 FilteredS 
ubsetEval 
Genetic 
Search 
 3 29, 33, 34 
FS12 Filtered 
SubsetEval 
RankSearch  4 23, 29, 33, 34 
FS13 Wrapper 
SubsetEval 
BestFirst Naïve 
Bayes 
2 20, 34 
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Table 21 
Cont. 
FS14 Wrapper 
SubsetEval 
BestFirst Bagging 11 12, 13, 14, 17, 20, 29, 30, 33, 34, 
37, 38 
FS15 Wrapper 
SubsetEval 
Genetic 
Search 
Bagging 16 12, 13, 16, 17, 18, 19, 20, 21, 22, 
25, 28, 29, 33, 35, 36, 37 
FS16 Wrapper 
SubsetEval 
Greedy 
Stepwise 
Naïve 
Bayes 
2 20, 34 
FS17 Wrapper 
SubsetEval 
Linear 
Forward 
Selection 
Naïve 
Bayes 
8 20, 23, 27, 28, 29, 33, 34, 38 
FS18 Wrapper 
SubsetEval 
RankSearch Naïve 
Bayes 
4 23, 29, 33, 34 
FS19 Wrapper 
SubsetEval 
Subset 
SizeForward
Selection 
Naïve 
Bayes 
2 20, 34 
FS20 Wrapper 
SubsetEval 
Subset 
SizeForward
Selection 
Bagging 11 12, 13, 14, 17, 20, 29, 30, 33, 34, 
37, 38 
 
Table 22 exhibits the results of the classification process on the clean clinical dataset. We 
calculated the accuracy (AC), precision (PR), recall (RC) and F-measure (FM). FS14 A1 and 
FS20 A1 (89.8275%) ranked highest in accuracy, FS13 A8, FS16 A8 and FS19 A8 (0.974) in 
precision FS14 A6 and FS20 A6 (0.515) for recall and FS14 A6 and FS20 A6 for F-Measure 
(0.613).  
 The clean clinical elapsed table featured in Table 23 shows that based on the sum of the 
time elapsed for feature selection and classification, FS10 and FS11 (0:00:05) had the best 
performance and FS15 (0:06:29) had the poorest performance.
 
 
 
Table 22 
Clean Clinical: Precision, Recall and F-Measure Rates 
Features Classifiers 
Name Metric A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 AC 88.3403% 86.972% 87.6264% 86.4366% 86.2582% 88.5187% 87.091% 88.6377% 88.9352% 
  PR 0.73 0.703 0.697 0.65 0.709 0.748 0.664 0.91 0.787 
  RC 0.409 0.295 0.375 0.295 0.212 0.405 0.36 0.307 0.405 
  FM 0.524 0.416 0.488 0.406 0.327 0.526 0.467 0.459 0.535 
FS2 AC 88.3403% 86.972% 87.6264% 86.4366% 86.2582% 88.5187% 87.091% 88.6377% 88.9352% 
  PR 0.73 0.703 0.697 0.65 0.709 0.748 0.664 0.91 0.787 
  RC 0.409 0.295 0.375 0.295 0.212 0.405 0.36 0.307 0.405 
  FM 0.524 0.416 0.488 0.406 0.327 0.526 0.467 0.459 0.535 
FS3 AC 88.2808% 87.4479% 87.6264% 86.4366% 86.2582% 88.5187% 86.7936% 88.6377% 88.2808% 
  PR 0.731 0.748 0.697 0.65 0.709 0.748 0.667 0.91 0.731 
  RC 0.402 0.303 0.375 0.295 0.212 0.405 0.318 0.307 0.402 
  FM 0.518 0.431 0.488 0.406 0.327 0.526 0.431 0.459 0.518 
FS4 AC 86.3772% 86.2582% 86.3772% 86.3772% 86.3772% 86.4961% 86.3772% 84.2951% 86.1392% 
  PR 0.778 0.789 0.818 0.761 0.761 0.894 0.761 0 0.772 
  RC 0.186 0.17 0.17 0.193 0.193 0.159 0.193 0 0.167 
  FM 0.3 0.28 0.282 0.308 0.308 0.27 0.308 0 0.274 
FS5 AC 88.7567% 87.4479% 87.8049% 86.9126% 87.1505% 89.4111% 87.8049% 89.0541% 88.8162% 
  PR 0.733 0.73 0.686 0.647 0.669 0.75 0.675 0.877 0.732 
  RC 0.447 0.318 0.413 0.367 0.36 0.489 0.432 0.352 0.455 
  FM 0.555 0.443 0.515 0.469 0.468 0.592 0.527 0.503 0.561 
FS6 AC 89.3516% 87.2695% 87.9833% 86.7936% 87.1505% 89.0541% 87.8049% 88.9352% 89.2326% 
  PR 0.771 0.716 0.691 0.642 0.669 0.725 0.675 0.868 0.771 
  RC 0.458 0.314 0.424 0.36 0.36 0.489 0.432 0.348 0.447 
  FM 0.575 0.437 0.526 0.461 0.468 0.584 0.527 0.497 0.566 78 
 
 
 
Table 22 
Cont.  
FS7 AC 88.7567% 87.4479% 87.8049% 86.9126% 87.1505% 89.4111% 87.8049% 89.0541% 88.8162% 
  PR 0.733 0.73 0.686 0.647 0.669 0.75 0.675 0.877 0.732 
  RC 0.447 0.318 0.413 0.367 0.36 0.489 0.432 0.352 0.455 
  FM 0.555 0.443 0.515 0.469 0.468 0.592 0.527 0.503 0.561 
FS8 AC 88.9352% 86.3772% 87.8049% 86.9126% 87.1505% 89.2326% 87.8049% 88.9946% 88.5187% 
  PR 0.738 0.684 0.686 0.647 0.669 0.729 0.675 0.869 0.713 
  RC 0.458 0.246 0.413 0.367 0.36 0.5 0.432 0.352 0.451 
  FM 0.565 0.362 0.515 0.469 0.468 0.593 0.527 0.501 0.552 
FS9 AC 88.7567% 87.4479% 87.8049% 86.9126% 87.1505% 89.4111% 87.8049% 89.0541% 88.8162% 
  PR 0.733 0.73 0.686 0.647 0.669 0.75 0.675 0.877 0.732 
  RC 0.447 0.318 0.413 0.367 0.36 0.489 0.432 0.352 0.455 
  FM 0.555 0.443 0.515 0.469 0.468 0.592 0.527 0.503 0.561 
FS10 AC 86.9126% 85.8418% 86.3177% 86.6151% 86.1392% 86.8531% 87.1505% 86.7936% 86.7936% 
  PR 0.775 0.641 0.693 0.741 0.731 0.753 0.786 0.862 0.744 
  RC 0.235 0.223 0.231 0.227 0.186 0.242 0.25 0.189 0.242 
  FM 0.36 0.331 0.347 0.348 0.296 0.367 0.379 0.311 0.366 
FS11 AC 86.9126% 85.8418% 86.3177% 86.6151% 86.1392% 86.8531% 87.1505% 86.7936% 86.7936% 
  PR 0.775 0.641 0.693 0.741 0.731 0.753 0.786 0.862 0.744 
  RC 0.235 0.223 0.231 0.227 0.186 0.242 0.25 0.189 0.242 
  FM 0.36 0.331 0.347 0.348 0.296 0.367 0.379 0.311 0.366 
FS12 AC 86.9126% 86.1987% 86.4366% 86.8531% 86.1392% 86.972% 87.091% 86.4961% 87.0910% 
  PR 0.775 0.67 0.7 0.753 0.731 0.765 0.764 0.863 0.742 
  RC 0.235 0.239 0.239 0.242 0.186 0.246 0.258 0.167 0.273 
  FM 0.36 0.352 0.356 0.367 0.296 0.372 0.385 0.279 0.399 
FS13 AC 86.7341% 86.6151% 86.7936% 86.3772% 86.3772% 86.7341% 86.7936% 86.4961% 86.6746% 
  PR 0.847 0.81 0.85 0.761 0.761 0.847 0.85 0.974 0.845 
  RC 0.189 0.193 0.193 0.193 0.193 0.189 0.193 0.144 0.186 
  FM 0.31 0.312 0.315 0.308 0.308 0.31 0.315 0.251 0.304 79 
 
 
 
Table 22 
Cont.  
FS14 AC 89.8275% 87.4479% 89.4706% 85.5443% 85.7823% 89.768% 88.2213% 88.9352% 89.3516% 
  PR 0.782 0.785 0.754 0.571 0.575 0.756 0.672 0.842 0.746 
  RC 0.489 0.277 0.489 0.318 0.364 0.515 0.489 0.364 0.489 
  FM 0.601 0.409 0.593 0.409 0.445 0.613 0.566 0.508 0.59 
FS15 AC 89.649% 84.5925% 88.6972% 83.7002% 86.9126% 89.2326% 87.4479% 88.5782% 89.0541% 
  PR 0.788 0.619 0.715 0.473 0.69 0.755 0.651 0.853 0.753 
  RC 0.466 0.049 0.466 0.326 0.303 0.466 0.432 0.33 0.451 
  FM 0.586 0.091 0.564 0.386 0.421 0.576 0.519 0.475 0.564 
FS16 AC 86.7341% 86.6151% 86.7936% 86.3772% 86.3772% 86.7341% 86.7936% 86.4961% 86.6746% 
  PR 0.847 0.81 0.85 0.761 0.761 0.847 0.85 0.974 0.845 
  RC 0.189 0.193 0.193 0.193 0.193 0.189 0.193 0.144 0.186 
  FM 0.31 0.312 0.315 0.308 0.308 0.31 0.315 0.251 0.304 
FS17 AC 87.9833% 86.6151% 88.5187% 87.091% 86.6746% 88.4593% 86.972% 88.5782% 88.3403% 
  PR 0.691 0.714 0.713 0.753 0.756 0.719 0.669 0.909 0.687 
  RC 0.424 0.246 0.451 0.265 0.223 0.436 0.337 0.303 0.473 
  FM 0.526 0.366 0.552 0.392 0.345 0.542 0.448 0.455 0.561 
FS18 AC 86.9126% 86.1987% 86.4366% 86.8531% 86.1392% 86.972% 87.091% 86.4961% 87.091% 
  PR 0.775 0.67 0.7 0.753 0.731 0.765 0.764 0.863 0.742 
  RC 0.235 0.239 0.239 0.242 0.186 0.246 0.258 0.167 0.273 
  FM 0.36 0.352 0.356 0.367 0.296 0.372 0.385 0.279 0.399 
FS19 AC 86.7341% 86.6151% 86.7936% 86.3772% 86.3772% 86.7341% 86.7936% 86.4961% 86.6746% 
  PR 0.847 0.81 0.85 0.761 0.761 0.847 0.85 0.974 0.845 
  RC 0.189 0.193 0.193 0.193 0.193 0.189 0.193 0.144 0.186 
  FM 0.31 0.31 0.315 0.308 0.308 0.31 0.315 0.251 0.304 
FS20 AC 89.8275% 87.4479% 89.4706% 85.5443% 85.7823% 89.768% 88.2213% 88.9352% 89.3516% 
  PR 0.782 0.785 0.754 0.571 0.575 0.756 0.672 0.842 0.746 
  RC 0.489 0.277 0.489 0.318 0.364 0.515 0.489 0.364 0.489 
  FM 0.601 0.409 0.593 0.409 0.445 0.613 0.566 0.508 0.59 80 
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Table 23 
Clean Clinical Time Elapsed 
Features Classifiers (Time Elapsed) 
Name Time A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 0:00:00 0:00:00 0:00:01 0:00:00 0:00:01 0:00:01 0:00:01 0:00:02 0:00:03 0:00:02 
FS2 0:00:00 0:00:01 0:00:00 0:00:01 0:00:00 0:00:01 0:00:01 0:00:01 0:00:02 0:00:02 
FS3 0:00:00 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:03 0:00:02 
FS4 0:00:01 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:02 0:00:01 
FS5 0:00:00 0:00:01 0:00:00 0:00:01 0:00:00 0:00:01 0:00:01 0:00:01 0:00:05 0:00:03 
FS6 0:00:00 0:00:02 0:00:01 0:00:01 0:00:00 0:00:01 0:00:02 0:00:02 0:00:06 0:00:04 
FS7 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:02 0:00:02 0:00:04 0:00:03 
FS8 0:00:00 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:05 0:00:03 
FS9 0:00:00 0:00:01 0:00:01 0:00:01 0:00:01 0:00:01 0:00:02 0:00:01 0:00:04 0:00:03 
FS10 0:00:00 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:01 
FS11 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:00 0:00:02 0:00:01 
FS12 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:02 0:00:01 
FS13 0:00:06 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:01 
FS14 0:03:40 0:00:00 0:00:01 0:00:00 0:00:00 0:00:01 0:00:02 0:00:02 0:00:04 0:00:03 
FS15 0:06:10 0:00:02 0:00:01 0:00:00 0:00:00 0:00:02 0:00:02 0:00:02 0:00:06 0:00:04 
FS16 0:00:02 0:00:00 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:00 0:00:01 0:00:01 
FS17 0:00:20 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:04 0:00:02 
FS18 0:00:06 0:00:00 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:00 0:00:02 0:00:01 
FS19 0:00:02 0:00:00 0:00:00 0:00:01 0:00:00 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 
FS20 0:02:37 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:02 0:00:01 0:00:05 0:00:03 
 
When considering runtime, reduction in features and recall in Figure 11 below, we have 
determined that FS20 A6 is the better algorithm to use for this dataset. 
 
Figure 11. Top Three Clean Clinical. 
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5.7 Clean Medical Dataset   
Table 24 displays the results of the feature selection process on the clean medical dataset. 
Based solely on feature reduction, FS16 was the top ranking performer by reducing the features 
down to a feature set of 4. FS6 was the lowest ranking performer by only reducing the features 
down to a feature set of 170.  
Table 24 
Clean Medical Feature Set 
Clinical  Feature Set 
Set Attribute  
Evaluator 
Search  
Method 
Classifier # of 
Feat. 
Selected Feature List 
FS1 Cfs Subset 
Eval 
BestFirst  13 43, 105, 248, 285, 320, 322, 338, 
404, 411, 414, 416, 417, 418 
FS2 Cfs Subset 
Eval 
Genetic 
Search 
 84 39, 53, 54, 64, 70, 73, 76, 81, 86, 
89, 90, 97, 104, 105, 108, 113, 120, 
123, 124, 125, 130, 139, 149, 151, 
152, 157, 159, 164, 174, 177, 181, 
187, 188, 195, 196, 199, 201, 206, 
208, 209, 213, 224, 226, 227, 234, 
240, 244, 247, 250, 256, 257, 263, 
264, 272, 280, 282, 295, 296, 298, 
299, 300, 301, 311, 318, 320, 332, 
338, 354, 355, 356, 375, 381, 397, 
398, 402, 404, 405, 406, 411, 412, 
413, 414, 417, 418 
FS3 Cfs 
SubsetEval 
RankSearch  16 43, 91, 104, 105, 248, 256, 320, 
327, 338, 394, 404, 411, 414, 416, 
417, 418 
FS4 Classifier 
SubsetEval 
Genetic 
Search 
OneR 39 39, 53, 64, 69, 70, 73, 86, 90, 95, 
97, 105, 113, 123, 130, 152, 164, 
195, 199, 206, 208, 224, 226, 234, 
253, 257, 272, 279, 290, 298, 301, 
313, 356, 379, 381, 406, 409, 411, 
417 
FS5 Consistency 
SubsetEval 
BestFirst  11 105, 141, 245, 248, 411, 412, 413, 
414, 416, 417, 418 
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Table 24 
Cont. 
FS6 Consistency 
SubsetEval 
Genetic 
Search 
 170 39, 40, 42, 46, 53, 54, 56, 57, 58, 
62, 63, 66, 67, 70, 71, 73, 77, 78, 
79, 81, 82, 83, 84, 86, 88, 91, 93, 
94, 97, 99, 101, 103, 105, 106, 111, 
112, 113, 115, 117, 120, 121, 122, 
123, 124, 125, 126, 128, 129, 132, 
133, 138, 139, 141, 142, 143, 145, 
146, 150, 151, 152, 153, 156, 160, 
167, 169, 170, 171, 173, 176, 180, 
182, 184, 185, 186, 187, 188, 193, 
200, 203, 205, 207, 208, 212, 213, 
214, 215, 216, 220, 223, 224, 230, 
231, 233, 239, 240, 242, 243, 245, 
247, 248, 251, 252, 254, 255, 256, 
258, 259, 260, 262, 264, 272, 276, 
277, 282, 284, 285, 299, 302, 305, 
309, 310, 312, 321, 325, 333, 334, 
335, 336, 337, 338, 344, 347, 350, 
351, 356, 357, 362, 363, 364, 365, 
366, 369, 370, 371, 372, 373, 374, 
375, 382, 383, 384, 385, 387, 390, 
391, 392, 395, 397, 398, 399, 403, 
405, 406, 410, 411, 412, 413, 415, 
416, 418 
FS7 Consistency 
SubsetEval 
Linear 
Forward 
Selection 
 11 49, 105, 285, 320, 338, 357, 411, 
414, 416, 417, 418 
FS8 Consistency 
SubsetEval 
RankSearch  82 43, 49, 53, 54, 63, 64, 69, 88, 91, 
104, 105, 112, 120, 122, 123, 124, 
126, 129, 131, 135, 139, 141, 145, 
148, 157, 159, 162, 163, 164, 171, 
172, 191, 207, 209, 218, 226, 229, 
230, 245, 248, 249, 250, 251, 254, 
256, 262, 275, 279, 282, 285, 296, 
297, 298, 311, 318, 320, 321, 322, 
324, 325, 327, 334, 335, 337, 338, 
339, 355, 357, 359, 375, 384, 394, 
400, 404, 409, 411, 412, 413, 414, 
416, 417, 418 
FS9 Consistency 
SubsetEval 
Subset 
SizeForward
Selection 
 9 49, 105, 285, 357, 411, 414, 416, 
417, 418 
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Table 24 
Cont. 
FS10 Filtered 
SubsetEval 
BestFirst  10 105, 285, 320, 338, 404, 411, 414, 416, 
417, 418 
FS11 Filtered 
SubsetEval 
Genetic 
Search 
 84 39, 53, 54, 64, 70, 73, 76, 81, 86, 89, 90, 
97, 104, 105, 108, 113, 120, 123, 124, 
125, 130, 139, 149, 151, 152, 157, 159, 
164, 174, 177, 181, 187, 188, 195, 196, 
199, 201, 206, 208, 209, 213, 224, 226, 
227, 234, 240, 244, 247, 250, 256, 257, 
263, 264, 272, 280, 282, 295, 296, 298, 
299, 300, 301, 311, 318, 320 ,332, 338, 
354, 355, 356, 375, 381, 397, 398, 402, 
404, 405, 406, 411, 412, 413, 414, 417, 
418 
FS12 Filtered 
SubsetEval 
Rank 
Search 
 10 91, 104, 256, 320, 327, 338, 404, 411, 
414, 417 
FS13 Wrapper 
SubsetEval 
BestFirst Naïve 
Bayes 
9 41, 45, 145, 172, 228, 285, 334, 411, 
416 
FS14 Wrapper 
SubsetEval 
BestFirst Bagging 8 46, 179, 244, 381, 402, 409, 411, 415 
FS15 Wrapper 
SubsetEval 
Genetic 
Search 
Bagging 169 39, 42, 43, 45, 49, 50, 51, 55, 58, 61, 63, 
65, 66, 67, 68, 70, 71, 73, 77, 78, 79, 80, 
82, 86, 88, 89, 91, 94, 97, 99, 100, 101, 
102, 105, 109, 110, 111, 112, 113, 115, 
116, 119, 121, 127, 131, 132, 137, 139, 
141, 142, 145, 147, 149, 150, 152, 153, 
155, 156, 157, 163, 164, 166, 167, 170, 
173, 174, 176, 177, 181, 183, 185, 186, 
187, 188, 189, 197, 198, 200, 202, 203, 
204, 205, 220, 223, 224, 226, 228, 231, 
233, 236, 237, 238, 242, 247, 251, 252, 
253, 255, 256, 257, 260, 262, 264, 265, 
267, 270, 272, 273, 274 277, 278, 279, 
281, 282, 284, 285, 286, 288, 289, 290, 
294, 298, 301, 305, 312, 313, 316, 321, 
324, 33,3 339, 340, 341, 345, 346, 349, 
353, 357, 360, 361, 363, 364, 365, 366, 
367, 371, 375, 380, 382, 383, 384, 387, 
388, 390, 391, 392, 395, 398, 399 403, 
404, 405, 406, 409, 411, 413, 415, 416 
417 
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FS16 Wrapper 
SubsetEval 
Greedy 
Stepwise 
Naïve 
Bayes 
4 130, 145, 285, 411 
FS17 Wrapper 
SubsetEval 
Linear 
Forward 
Selection 
Naïve 
Bayes 
9 104, 105, 124, 285, 327, 337, 338, 411, 
417 
FS18 Wrapper 
SubsetEval 
RankSearch Naïve 
Bayes 
10 91, 104, 256, 320, 327, 338, 404, 411, 
414, 417 
FS19 Wrapper 
SubsetEval 
Subset 
SizeForward
Selection 
Naïve 
Bayes 
5 104, 105, 285, 411, 417 
FS20 Wrapper 
SubsetEval 
Subset 
SizeForward
Selection 
Bagging 9 120, 276, 282, 285, 320, 404, 411, 416, 
417 
 
Table 25 exhibits the results of the classification process on the clean medical dataset. 
We calculated the accuracy (AC), precision (PR), recall (RC) and F-measure (FM). FS1 A6, FS5 
A3 and FS17 A4 (97.0256%) were equal in accuracy, FS4 A8 (0.969) in precision FS17 A2 
(0.92) for recall and FS5 A3 and FS17 A4 for F-Measure (0.903). Based solely on AC and FM, 
FS17 A4 is the top ranking performer.  
 The clean medical time elapsed table featured in Table 26 shows that based on the sum of 
the time elapsed for feature selection and classification, FS9 (0:00:22) had the best performance 
and FS15 (0:59:26) had the poorest performance.
 
 
 
Table 25 
Clean Medical: Precision, Recall and F-Measure Rates 
Features Classifiers 
Name Metric A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 AC 96.2522% 96.6092% 96.2522% 96.4307% 95.9548% 97.0256% 96.4902% 96.3712% 96.2522% 
  PR 0.894 0.9 0.885 0.889 0.877 0.931 0.908 0.925 0.888 
  RC 0.864 0.883 0.875 0.883 0.864 0.875 0.864 0.837 0.871 
  FM 0.879 0.891 0.88 0.886 0.87 0.902 0.885 0.879 0.88 
FS2 AC 96.3712% 93.2183% 96.0738% 94.5271% 95.8358% 96.9661% 96.0143% ERROR 96.2522% 
  PR 0.944 0.762 0.899 0.795 0.862 0.946 0.883  0.897 
  RC 0.86 0.826 0.845 0.879 0.875 0.856 0.86  0.86 
  FM 0.882 0.793 0.871 0.835 0.868 0.899 0.871  0.878 
FS3 AC 96.0738% 95.8358% 96.4902% 96.2522% 95.8953% 96.6092% 96.4307% 95.8358% 96.4307% 
  PR 0.893 0.873 0.893 0.9 0.871 0.916 0.902 0.918 0.905 
  RC 0.852 0.86 0.883 0.856 0.867 0.864 0.867 0.807 0.864 
  FM 0.872 0.866 0.888 0.878 0.869 0.889 0.884 0.859 0.884 
FS4 AC 96.1927% 93.4563% 96.2522% 95.3004% 95.8358% 95.6573% 95.8953% 95.122% 95.8953% 
  PR 0.913 0.806 0.921 0.849 0.862 0.863 0.874 0.969 0.901 
  RC 0.837 0.769 0.833 0.852 0.875 0.86 0.864 0.712 0.83 
  FM 0.874 0.787 0.875 0.851 0.868 0.861 0.869 0.821 0.864 
FS5 AC 96.3712% 96.6092% 97.0256% 96.4902% 95.8358% 96.8471% 96.5497% 96.2522% 96.3117% 
  PR 0.901 0.916 0.921 0.905 0.862 0.924 0.909 0.943 0.891 
  RC 0.864 0.864 0.886 0.867 0.875 0.871 0.867 0.811 0.871 
  FM 0.882 0.889 0.903 0.886 0.868 0.897 0.888 0.872 0.881 
FS6 AC 96.6686% 86.5556% 96.6092% 94.4676% 96.2522% 96.9661% 96.8471% ERROR 95.8953% 
  PR 0.903 0.711 0.9 0.798 0.885 0.928 0.92   0.871 
  RC 0.883 0.242 0.883 0.867 0.875 0.875 0.875   0.867 
  FM 0.893 0.362 0.891 0.831 0.88 0.901 0.897   0.869 86 
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Cont.  
FS7 AC 96.4307% 96.2522% 95.7763% 96.1333% 95.9548% 96.6092% 96.4902% 96.6092% 96.1333% 
  PR 0.905 0.879 0.864 0.867 0.877 0.919 0.908 0.94 0.884 
  RC 0.864 0.883 0.867 0.89 0.864 0.86 0.864 0.837 0.867 
  FM 0.884 0.881 0.866 0.879 0.87 0.888 0.885 0.886 0.876 
FS8 AC 96.6686% 93.6942% 96.6686% 93.5158% 95.8358% 96.9066% 96.5497% 60.2023% 96.3117% 
  PR 0.913 0.797 0.919 0.751 0.862 0.938 0.909 0.904 0.885 
  RC 0.871 0.803 0.864 0.879 0.875 0.86 0.867 0.688 0.879 
  FM 0.891 0.8 0.891 0.81 0.868 0.897 0.888 0.782 0.882 
FS9 AC 96.4307% 96.0143% 96.1927% 96.2522% 95.9548% 96.9661% 96.4902% 96.6092% 96.1927% 
  PR 0.902 0.866 0.885 0.865 0.877 0.921 0.908 0.94 0.882 
  RC 0.867 0.883 0.871 0.902 0.864 0.883 0.864 0.837 0.875 
  FM 0.884 0.874 0.878 0.883 0.87 0.901 0.885 0.886 0.878 
FS10 AC 96.3117% 96.3712% 96.1927% 96.2522% 95.9548% 96.9661% 96.4902% 96.1927% 96.4307% 
  PR 0.898 0.886 0.888 0.879 0.877 0.931 0.908 0.924 0.892 
  RC 0.864 0.883 0.867 0.883 0.864 0.871 0.864 0.826 0.879 
  FM 0.88 0.884 0.877 0.881 0.87 0.9 0.885 0.872 0.885 
FS11 AC 96.3712% 93.2183% 96.0738% 94.5271% 95.8358% 96.9661% 96.0143% ERROR 96.2522% 
  PR 0.904 0.762 0.899 0.795 0.862 0.946 0.883   0.897 
  RC 0.86 0.826 0.845 0.879 0.875 0.856 0.86   0.86 
  FM 0.882 0.793 0.871 0.835 0.868 0.899 0.871   0.878 
FS12 AC 95.8953% 95.8953% 95.7763% 96.1333% 95.8358% 95.4194% 95.9548% 95.122% 96.3117% 
  PR 0.892 0.885 0.918 0.913 0.862 0.87 0.871 0.96 0.935 
  RC 0.841 0.848 0.803 0.833 0.875 0.833 0.871 0.72 0.822 
  FM 0.865 0.867 0.857 0.871 0.868 0.851 0.871 0.823 0.875 
FS13 AC 96.3712% 96.7876% 96.4902% 96.9066% 95.8953% 96.4307% 96.3712% 96.4307% 96.4902% 
  PR 0.889 0.917 0.89 0.902 0.876 0.905 0.898 0.915 0.89 
  RC 0.879 0.875 0.886 0.902 0.86 0.864 0.867 0.852 0.886 
  FM 0.884 0.895 0.888 0.902 0.868 0.884 0.882 0.882 0.888 87 
 
 
 
Table 25 
Cont.  
FS14 AC 96.4902% 94.3486% 96.3712% 94.765% 95.8358% 96.1333% 96.3117% 95.4194% 96.2522% 
  PR 0.912 0.851 0.911 0.841 0.862 0.896 0.895 0.952 0.907 
  RC 0.86 0.777 0.852 0.822 0.875 0.852 0.867 0.746 0.848 
  FM 0.885 0.812 0.881 0.831 0.868 0.874 0.881 0.837 0.877 
FS15 AC 96.5497% 89.1136% 96.9066% 95.003% 96.2522% 96.7281% 96.7876% ERROR 96.3117% 
  PR 0.893 0.694 0.921 0.808 0.885 0.92 0.92   0.888 
  RC 0.886 0.549 0.879 0.894 0.875 0.867 0.871   0.875 
  FM 0.89 0.613 0.899 0.849 0.88 0.893 0.895   0.882 
FS16 AC 96.3712% 96.2522% 96.2522% 96.6686% 95.8358% 95.0625% 96.3117% 93.7537% 96.6092% 
  PR 0.889 0.894 0.868 0.882 0.862 0.849 0.888 0.954 0.897 
  RC 0.879 0.864 0.898 0.909 0.875 0.833 0.875 0.633 0.886 
  FM 0.884 0.879 0.883 0.896 0.868 0.841 0.882 0.761 0.891 
FS17 AC 96.1333% 96.3117% 96.0738% 97.0256% 95.8358% 96.1333% 95.8358% 94.2891% 96.6092% 
  PR 0.9 0.856 0.878 0.925 0.862 0.887 0.865 0.947 0.888 
  RC 0.848 0.92 0.871 0.883 0.875 0.864 0.871 0.674 0.898 
  FM 0.873 0.887 0.875 0.903 0.868 0.875 0.868 0.788 0.893 
FS18 AC 95.8953% 95.8953% 95.7763% 96.1333% 95.8358% 95.4194% 95.9548% 95.122% 96.3117% 
  PR 0.892 0.885 0.918 0.913 0.862 0.87 0.871 0.96 0.935 
  RC 0.841 0.848 0.803 0.833 0.875 0.833 0.871 0.72 0.822 
  FM 0.865 0.867 0.857 0.871 0.868 0.851 0.871 0.823 0.875 
FS19 AC 96.1927% 96.4902% 96.0738% 96.8471% 95.8358% 96.1927% 95.8358% 94.5271% 96.4307% 
  PR 0.903 0.873 0.878 0.901 0.862 0.882 0.865 0.943 0.889 
  RC 0.848 0.909 0.871 0.898 0.875 0.875 0.871 0.693 0.883 
  FM 0.875 0.891 0.875 0.899 0.868 0.878 0.868 0.799 0.886 
FS20 AC 96.6092% 96.0738% 96.1333% 96.3712% 95.8953% 96.6092% 96.3117% 96.3712% 96.0738% 
  PR 0.9 0.884 0.89 0.901 0.876 0.912 0.901 0.951 0.899 
  RC 0.883 0.864 0.86 0.864 0.86 0.867 0.86 0.811 0.845 
  FM 0.891 0.874 0.875 0.882 0.868 0.889 0.88 0.875 0.871 88 
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Table 26 
Clean Medical Time Elapsed 
Features Classifiers (Time Elapsed) 
Name Time A1 A2 A3 A4 A5 A6 A7 A8 A9 
FS1 0:00:00 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:02 0:00:16 0:00:02 
FS2 0:00:08 0:00:03 0:00:03 0:00:03 0:00:01 0:00:07 0:00:05 0:00:13 0:00:43 0:00:15 
FS3 0:00:09 0:00:01 0:00:02 0:00:01 0:00:00 0:00:01 0:00:01 0:00:02 0:00:17 0:00:02 
FS4 0:00:15 0:00:02 0:00:01 0:00:01 0:00:01 0:00:03 0:00:05 0:00:06 0:00:16 0:00:03 
FS5 0:00:05 0:00:00 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:02 0:00:22 0:00:02 
FS6 0:00:03 0:00:06 0:00:04 0:00:08 0:00:01 0:00:13 0:00:05 0:00:26 0:01:58 0:00:23 
FS7 0:00:02 0:00:00 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:02 0:00:15 0:00:01 
FS8 0:00:03 0:00:03 0:00:02 0:00:03 0:00:01 0:00:07 0:00:03 0:00:13 0:00:50 0:00:09 
FS9 0:00:02 0:00:00 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:14 0:00:02 
FS10 0:00:01 0:00:00 0:00:01 0:00:01 0:00:01 0:00:01 0:00:01 0:00:02 0:00:15 0:00:01 
FS11 0:00:08 0:00:03 0:00:03 0:00:04 0:00:01 0:00:07 0:00:05 0:00:13 0:00:42 0:00:11 
FS12 0:00:08 0:00:01 0:00:00 0:00:01 0:00:00 0:00:01 0:00:01 0:00:02 0:00:09 0:00:01 
FS13 0:07:55 0:00:01 0:00:00 0:00:00 0:00:00 0:00:01 0:00:02 0:00:02 0:00:10 0:00:01 
FS14 0:27:31 0:00:01 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:09 0:00:02 
FS15 0:56:05 0:00:06 0:00:06 0:00:08 0:00:01 0:00:13 0:00:06 0:00:25 0:01:53 0:00:23 
FS16 0:01:28 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:04 0:00:01 
FS17 0:01:19 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:02 0:00:02 0:00:06 0:00:01 
FS18 0:16:45 0:00:00 0:00:00 0:00:00 0:00:00 0:00:01 0:00:00 0:00:02 0:00:00 0:00:02 
FS19 0:00:20 0:00:01 0:00:01 0:00:00 0:00:00 0:00:01 0:00:01 0:00:01 0:00:05 0:00:01 
FS20 0:04:28 0:00:01 0:00:01 0:00:01 0:00:00 0:00:01 0:00:01 0:00:01 0:00:10 0:00:02 
 
When considering runtime, reduction in features and recall in Figure 12 below, we have 
determined that FS5 A3 is the better algorithm to use for this dataset. 
 
Figure 12. Top Three Clean Medical. 
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There is a vast amount of results from our experiment; however, after analyzing all of the 
experiments performed, and considering overall accuracy, runtime, reduction in features and 
recall, we have determined that FS16 A9 of the raw full dataset is the better algorithm to use for 
this problem. We gave more weight to recall than precision because if BV goes undiagnosed and 
therefore untreated, it can cause very harmful effects for women. On the other hand, if a woman 
is diagnosed as BV positive but in reality is negative (false positive); the consequence will 
merely be taking an inexpensive anti-biotic which will cause little to no harm for women. While 
the difference between the false negative outcomes for this data seems minimal, approximately 1 
million pregnant women are diagnosed with BV yearly. This fact highlights the significance of 
the results. Untreated BV in women increases the chance of pre-term labor and pelvic 
inflammatory disease (PID).  
The final feature set is constructed of features 2, 7, 29, 33, 34, 104, 130, 228, 241, 285, 
295, 411, 416 and 417. The feature names are displayed in Table 27. 
Table 27 
Final Feature Names 
P_ID VAG_ODOR Jonquetella corGroup6 
P_ID.1 Bacteria.10 Mycoplasma corGroup7 
TOB_USE Bifidobacterium Odoribacter 
 PH_GLOVE Haemophilus corGroup1 
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CHAPTER 6 
Conclusion and Future Research 
 In this thesis we conducted experiments using twenty different feature selection 
algorithms and analyzed the time taken by each of them. We used nine classification algorithms 
using the selected features in the previous step and studied the precision and recall of BV 
disease. Six additional datasets were created by conducting experiments on the data subsets and 
cleaning the data. We compared the accuracy, precision, recall, F-measure and runtime for each 
feature selection and classification combination. Some of the features were not present in many 
women and had minimal effect on the overall outcome. On the other hand, the features which 
were present in all the women have significant effect on the classification results.  
As the medical community continues to embrace machine learning approaches in order to 
discover ways to advance clinical studies, lower the cost of medication and aid physicians with 
expedited and more accurate diagnoses, research in this area must continue. Our future work will 
be dedicated towards conducting experiments with additional feature selection and classification 
algorithms, adjust the seed values of the deterministic algorithms to force randomization and 
manipulate the default settings on top performing algorithms. All of this will be done in an effort 
to find the optimal algorithm combinations to increase reduce features and increase accuracy for 
our BV dataset. 
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